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     Ethanol and 6-hydroxydopamine (6-OHDA), a Parkinson’s disease (PD) mimetic, are 
two toxins to the cerebellum. This study investigated the molecular mechanisms 
underlying their neurotoxicities. The work in chapter 2 of this thesis focused on 6-
OHDA-induced neurodegeneration. Previous studies indicate that impaired function of 
the endoplasmic reticulum (ER), commonly referred to as ER stress, is an important 
factor in the neuropathology of a wide variety of neurological disorders. This study 
demonstrated that 6-OHDA evoked ER-stress and led to apoptosis in SH-SY5Y neuronal 
cell line and cultured rat cerebellar granule neurons (CGNs). Furthermore, GSK3β played 
a crucial role in mediating 6-OHDA’s neurotoxicity. GSK3β inhibitors and neurotrophic 
factor, such as BDNF, protected neural cells against 6-OHDA-induced cell death. The 
results suggest that GSK3β is an important intermediate in proapoptotic signaling 
cascades that are associated with neurodegenerative disease, thus providing a potential 
taget site amenable to pharmacological intervention. The work in chapter 3 explored the 
intracellular signaling pathway that responds to ethanol-induced damage to the 
cerebellum. Numerous studies have found that early developmental exposure to ethanol 
caused profound damage to the cerebellum, leading to significant reduction in cerebellum 
volume, weight and protein content. PACT (Rax) / PKR / eIF2α is an important signal 
transducing pathway which controls the protein synthesis initiation response to different 
stimuli. Previous studies have shown that ethanol exposure decreases the protein content 
in rat cerebellum and inhibits protein synthesis initiation in rat heart, liver and skeletal 
muscle. This study demonstrated that the expressions of PACT (Rax) / PKR / eIF2α are 
developmentally regulated in rat developing cerebellum; ethanol exposure promotes the 
association of PACT (Rax) with PKR. Ethanol-induced interaction between PACT(Rax) 
and PKR leads to phosphorylation of eIF2α and protein synthesis initiation inhibition. 
This inhibition can be enhanced by over-expression of PACT (Rax) and reversed by a 
mutated PACT (Rax) gene at serine 18 or PKR inhibitors. The results provide a 
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1.      6-Hydroxydopamine, Glycogen Synthase Kinase 3β (GSK3β) and Neuronal     
Degeneration 
 
1.1.  ER stress and neuronal pathogenesis 
The endoplastic reticulum (ER) is an important intracellular compartment that 
regulates protein synthesis, protein folding and trafficking, cellular responses to stress, 
and intracellular calcium (Ca2+) levels (1-3). Alterations in Ca2+ homeostasis and 
accumulation of unfolded proteins in the ER cause ER stress (4;5). A variety of toxic 
insults, including Ca2+ ionophores, inhibitors of glycosylation, chemical toxicants, and 
oxidative stress can all cause ER stress and ultimately lead to cell death (6-14). Although 
the ER plays an essential role in important cell functions, until recently the possible 
involvement of the ER dysfunction in neuropathology such as ischemia, epileptic seizures 
and Alzheimer’s or Parkinson’s disease has been largely neglected. Much data show that 
ER function is disturbed in many acute and chronic diseases of the brain, for example: the 
ER-associated degradation of misfolded proteins is affected in Parkinson’s disease, the 
unfolded protein response is down-regulated in Alzheimer’s disease, and the ER calcium 
homeostasis is disturbed in ischemia (15-23). 
Neuronal viability is maintained through a complex interaction network of 
signaling pathways that can be perturbed in response to a multitude of cellular stresses. A 
shift in one or more of these pathways can alter the fate of a neuron resulting in cell death 
or continued survival (24;25). Apoptosis is a mechanism of cell death that plays a 
fundamental role during the development of many tissues or organs including the central 
nervous system. Apoptosis has traditionally been distinguished in developing tissues on 
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the basis of specific morphological and biochemical criteria, including perinuclear 
chromatin condensation, cell shrinkage and endonuclease-mediated internucleosomal 
DNA fragmentation into a ladder pattern. More recently, the term apoptosis has been 
used to describe the programmed biochemical pathways of cell death that accompany 
development, tissue injury and degeneration (26;27). Several studies indicated that ER 
stress was involved in certain types of neuronal apoptosis (28;29); however, the signal-
transducting events that connect ER stress to neuronal degeneration are incompletely 
understood (30-32).    
1.2. ER stress and GRP78 
The ER provides a unique oxidizing environment in which reside numerous 
protein chaperones that facilitate and promote the productive folding of proteins and 
protein complexes. These chaperones provide two important functions in protein folding 
(33-36). First, there are proteins such as protein disulfide isomerase (PDI) and cis-trans 
prolyl isomerase that catalyze protein-folding reactions and facilitate proteins to attain 
their final folded conformation. Second, there are protein chaperones that do not directly 
catalyze protein folding, but rather maintain proteins in a folding-competent state. 
Glucose-regulated protein (GRP) 78 is an ER chaperone protein whose expression is 
induced during oxidative stress, chemical toxity, treatment with Ca2+ ionophores and 
inhibitors of glycosylation. This induction, which is part of the unfolded protein response 
(UPR), is required to alleviate ER stress, maintain ER function, facilitate protein folding 
and thus protect cells from toxic insults (37;38). GRP78 is now considered an ER stress-
specific inducible family of proteins. 
1.3. ER stress and GADD153 
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A hallmark of the ER stress is the induction of ER stress-specific proteins such as 
GADD153 (Growth Arrest and DNA Damage inducible), also known as CHOP (C/EBP 
homologus protein) or CHOP10. It is a leucine zipper transcription factor that is present 
at low levels under normal conditions, but is robustly expressed in response to stress (39-
42). GADD153 functions as a negative regulator of C/EBP (CCAAT/enhancer-binding 
protein) transcription factors (43). It was originally identified based on its induction 
following treatment of cells with growth arresting and DNA damage agents, although 
induced expression of the gene has also been strongly tied to ER stress (44;45). In 
response to ER stress, the transcription factor GADD153 is induced at the transcriptional 
level (46). Several groups have reported that induction of GADD153 correlates with the 
onset of apoptosis (47-49). It was reported that cell killing in response to toxins that 
induce ER stress was delayed in embryonic fibroblasts derived from mice lacking the 
GADD153 gene (50). GADD153 is also regulated at the post-transcriptional level by 
phosphorylation. When phosphorylated on serine residues 78 and 81 by p38 MAP kinase, 
the transcriptional activation by GADD153 increases (51;52). Most evidence support that 
GADD153 negatively regulates cell growth and may induce apoptosis (53-55). However, 
the relationship between expression of GADD153 and cell death is still not very clear 
(56;57). 
1.3. ER stress and caspase 12 
Caspase stands for cysteine-dependent aspartate specific protease. All caspases 
are synthesized as inactive proenzymes and activated by proteolytic cleavage (58). 
Caspases have been divided into several distinct groups based on protein structure and 
putative functions (27). Caspase 12 in neurons, and other cells, is primarily associated 
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with the ER (59-62). Activation of caspase 12 from pro-caspase 12 is specifically induced 
by ER stress (63). Apoptosis triggered through pathways that do not involve the ER, such 
as serum deprivation or Fas activation, does not result in activation of caspase 12 (64-66). 
One of the properties of caspases is transactivation. Once initiator caspases are activated, 
they can proteolytically process executioner caspases (caspase 3, 6 and 7) into their active 
form (27). Although cytochrome c released from mitochondria has been believed to be 
required for caspase 9 activation during apoptosis (67;68), it was shown that caspase 12 
can activate pro-caspase 9. The activated caspase 9 then activated caspase 3 through a 
cytochrome C-independent pathway (69). Caspase 3 is one of the key executioners of 
apoptosis. During the execution phase of apoptosis, caspase 3 is responsible either 
partially or totally for the proteolytic cleavage of many key substrates, such as PARP 
(70). Caspase 3 is activated in the CNS in response to a variety of injurious stimuli 
including ischemia, exctotoxic insult, neurodegenerative disease and ER stress (71-77).  
1.4. ER stress and PERK/eIF2α 
  To survive and adapt under ER stress conditions, cells have a self-protective 
mechanism against ER stress which has been termed the ER stress response (78;79). 
There are four functionally distinct responses: First, cells upregulate the genes encoding 
ER chaperone proteins to increase protein-folding activity and to prevent protein 
aggregation. Second, the protein synthesis will be attenuated to reduce the load of new 
protein and to prevent further accumulation of unfolded proteins. Third, misfolded 
proteins will be degradated in the ER, and Fourth, cells undergo apoptotic death when 
functions of the ER are extensively impaired (80-82). To attenuate translation, this 
phenomenon occurs at the level of translational initiation via eIF2α phosphorylation (83-
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86). The factor eIF2α mediates the binding of the initiator Met-tRNA to the ribosome. 
Phosphorylation of eIF2α at Ser51 blocks this step and protein synthesis is inhibited. This 
induces cell apoptosis (85;87-90). PERK is an eIF2α kinase that is localized to the ER 
and responsible for phosphorylation of eIF2α during ER stress (91;92). Activation of 
PERK is triggered by the dissociation of GRP78 from its ER luminal domain as a 
consequence of ER stress. This leads to oligomerization and trans-autophosphorylation of 
PERK (93;94). 
1.5. PI3K, GSK-3β and apoptosis 
Phosphatidylinositol-3 kinase (PI3K) is one of the most important regulatory 
proteins that is involved in different signaling pathways and controlling of key functions 
of the cell. Experiments with the use of some specific inhibitors of PI3K or cell 
transfection with different PI3K gene variants reveal PI3K being a mediator in the control 
of at least two very important cell functions, namely, cell division (as a necessary 
component of the signaling pathway initiated by growth factors) and apoptosis (the 
progress of which is inhibited by PI3K) (95-99). The protein kinase Akt, which was first 
identified in the AKT virus, has been identified as a key downstream effector of PI3K in 
signaling cell survival (100-102). Neurotrophic factors such as NGF, BDNF and GDNF 
activate the PI3-Akt signaling cascade through corresponding receptor tyrosine kinases 
such as the high affinity neurotrophins receptors (Trks) (103). After receptor 
dimerization, PI3K is recruited to the plasma membrane where its catalytic subunit 
generates lipid second messengers, phosphoinositide phosphates (PIP2, PIP3) at the inner 
surface of the plasma membrane. Phosphoinositide-dependent protein kinase-1 (PDK-1) 
then acts in concert with PIP2 and PIP3 to phosphorylate and activate Akt (104). One of 
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the physiological targets of Akt is glycogen synthesis kinase-3 (GSK-3), which is 
inhibited by phosphorylation (105). There are two highly homologous forms of GSK-3 in 
mammals, GSK-3α and GSK-3β. GSK-3β is particularly abundant in the central nervous 
system where it is neuron specific (106). It has been confirmed that GSK-3 signaling has 
been implicated in neurodegeneration and neuronal apoptosis (107). GSK-3 is unusual in 
that it appears to be largely regulated by inhibition. One means by which GSK-3 can be 
inactivated is through phosphorylation of Ser9 in GSK-3β or Ser21 in the case of GSK-
3α (108). GSK-3β is also capable of being regulated by an activation pathway. Activation 
of GSK-3β can be accomplished by phosphorylation at Tyr216 (Tyr 279 for GSK-3α). 
Several cellular stresses including serum deprivation stimulate GSK-3β activity in 
cortical neurons prior to the induction of apoptosis (109). Inhibition of PI3K induced a 
form of cell death associated with the activation of GSK-3β (110). Expression of an 
inhibitory GSK-3β binding protein or a dominant interfering form of GSK-3β reduced 
neuronal apoptosis; overexpression of GSK-3β in neurons was sufficient to trigger 
neuronal cell death (105;111;112). GSK-3β is also a central compartment of the Wnt 
signaling pathway important for proper axis formation during embryonic development 
(113) and regulates cyclin D1 proteolysis and subcellular localization (114). However, 
the detail of this pathway that connects GSK-3β to apoptosis is still not clear. 
1.6. The chemicals and their functions: 
1.6.1. 6-Hydroxydopamine (6-OHDA): This is a selective catecholaminergic 
neurotoxin widely used to investigate the pathogenesis and progression of 
Parkinson’s disease (PD). The specificity of 6-OHDA neurotoxicity has been 
associated with its uptake and accumulation by a transport mechanism specific 
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for catecholaminergic neurons (115). It has been demonstrated that 
intrastriatal injection of 6-OHDA is a useful model for studying 
neuroprotective and neurotrophic therapies for PD (116). In this case, 6-
OHDA selectively eliminates the dopaminergic axons and terminals within a 
circumscribed area surrounding the injection site, which is followed by a 
degeneration of the parent nigral neurons. 6-OHDA has also been proposed as 
a putative neurotoxic factor in the pathogenesis of PD (105). This suggestion 
is based on the occurrence of 6-OHDA in both human brain (117) and urine of 
parkinsonian patients (118). Under physiological conditions 6-OHDA rapidly 
and nonenzymatically oxidized by molecular oxygen to form hydrogen 
peroxide (H2O2) and the corresponding p-quinone (119). Although the precise 
molecular mechanism of cytotoxicity for 6-OHDA remains uncertain, it has 
been often linked to the production of reactive oxygen species (ROS) 
(120;121). 
1.6.2. Thapsigargin is an effective inhibitor of the Ca2+ ion pump proteins of 
intracellular membrane located in sarcoplasmic reticulum (SR) and 
endoplasmic reticulum (ER) of skeletal, cardiac, muscle and brain 
microsomes (122;123). It interacts strongly with the SR of Ca2+-transport 
ATPase. The proposed mechanism of inhibition of Ca2+-ATPase activity 
including the inhibition of Ca2+ ion binding and enzyme phosphorylation have 
been reported (124-126). We use it as an inducer of ER stress. 
1.6.3. Tunicamycin: Tunicamycin is a mixture of homologous antibiotics which 
contain uracil, N-acetyl glycosamine, an 11-carbon aminodialdose called 
  8
tunicamine and a fatty acid linked to the amino group. It is an inhibitor of 
bacterial and eukaryote N-acetylglucosamine transferases; preventing 
formation of N-acetylglucosamine lipid intermediates and glycosylation of 
newly synthesized glycoproteins. Tunicamycin blocks the formation of 
protein N-glycosidic linkages by inhibiting the transfer of N-
acetylglycosamine 1-phosphate to dilichol monophosphate (127). 
1.6.4. GSK-3β inhibitor (TDZD-8): TDZD-8 (4-Benzyl-2-methyl-1,2,4,-
thiadiazoline-3,5-dione) is a thiadiazolidinone (TDZD) analog that acts as 
highly selective, non-ATP competitive inhibitor of GSK-3β by binding to the 
active site of GSK-3β. The molecular mechanism for this is still unknown 
(128). 
1.6.5. Lithium chloride (LiCl): LiCl  acts as a direct uncompetitive inhibitor of 
GSK-3β. The hypothesis that GSK-3β is the endogenous target of lithium 
action is supported by the genetic data as well as in vivo biochemical data and 
while the mechanism remains unknown (129). 
 
2.        Ethanol, PACT/Rax-PKR-eIF2α and protein synthesis 
 
2.1      Fetal Alcohol Syndrome and cerebellar dysfunction 
Alcohol has been widely recognized as a neuroteratogen (130) and maternal 
alcohol consumption during pregnancy can lead to central nervous system dysfunction in 
the new born known as the Fetal Alcohol Syndrome (FAS) (131;132), characterized by 
microcephaly, cognitive impairment, growth deficiency, a pattern of distinct facial 
features and central nervous system (CNS) disorders (133;134). FAS is considered the 
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most common nonhereditary cause of mental retardation (135). It was reported that there 
were 12,000 new cases of FAS yearly in 1999 in the US (132). The economic costs of 
alcohol abuse were estimated to have been $184.6 billion in 1998 among which FAS-
related economic costs were at least $4.15 billion (136). Although only 10-40% of infants 
of alcohol consumption women meet the criteria of full syndrome, more of them lack the 
characteristic facial defects and growth deficiency of FAS but still have alcohol-induced 
mental impairments, refer to as alcohol-related neurodevelopmental disorder (ARND) 
(135;137-139). 
The cerebellum is recognized for its functions in planning and coordinating 
movement, motor learning and plasticity, and maintaining balance (140). The cerebellum 
constitutes only 10% of the total volume of the brain but contains more than half of all its 
neurons (141). The cerebellum disorders induced by ethanol are common both in humans 
(142) and animals (143-146). There are two conspicuous neuronal populations in the 
cerebellum that differ both in size and the timing of their neurogenesis. The population of 
large Purkinje cells is generated exclusively prenatally in the rat, between gestational 
days 13 and 16 (147-149). A large population of small granule cells is formed almost 
exclusively postnatally during the first three weeks after birth (150). Alcohol exposure 
during the early postnatal period in the rat corresponds to exposure of the human fetus 
during part of the third trimester called the trimester equivalent (151;152). The 
developing cerebellum is one of the most vulnerable regions to ethanol both in human 
and in animals. Numerous animal model systems have been used to characterize FAS and 
ARND. One of these studies showed that in the growth of the rat brain but not the body 
was decreased, with cerebellum growth being inhibited twice as much compared with the 
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rest of the brain by exposure to ethanol (153). Other studies also showed that the ethanol 
exposure in rat pups lead to significant reduction in cerebellum volume, weight (154) and 
protein content (155). However the molecular mechanism(s) involved in ethanol-induced 
decrease in cerebellum size and inhibition of protein synthesis has not been elucidated. 
2.2.   PACT/Rax, PKR, eIF2α and protein synthesis 
 The double-stranded RNA-activated protein kinase (PKR) is a 551 (515 in mouse) 
amino acid serine/threonine protein kinase ubiquitously expressed in mammalian cells 
(156;157). PKR consists of two functionally distinct domains: an N-terminal dsRNA 
binding regulatory domain and the C-terminal catalytic domain. PKR is initially 
identified as transcriptionally induced by interferon and activated in virus-infected cells 
by double-stranded RNA (dsRNA) produced during the virus life cycle (158;159). It has 
been demonstrated that PKR is a component of signal transduction pathways mediating 
cell growth control, and response to stress (160). PKR can be activated by dsRNA, 
cytokines (161) and cell stresses such as growth factor or serum deprivation, bacterial 
products and physiochemical stress (162;163). A pair of dsRNA binding motifs located in 
the N-terminal domain of PKR act as a sensor to bind dsRNA or protein activators 
(which themselves contain dsRNA binding domains) (164). The known protein activators 
include PACT (PKR-activating protein) (165-167) and its mouse homologue RAX (168). 
PACT/Rax is also a ubiquitously expressed mammalian protein, which will be 
phosphorylated at serine 18 following stress, heterodimerizes with PKR and activates it 
in absence of dsRNA (169). Serine 18 of PACT/Rax is a crucial phosphorylation site for 
activation of PKR. The serine 18 mutated PACT/Rax can still associate with PKR, but 
has lost its kinase activity (170). Following binding, there is a conformational change in 
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PKR, which results in dimerization and autophosphorylation at Thr-446 and Thr-
451(171-178). Upon activation, PKR will phosphorylate its down stream substrates and 
the main cellular target of PKR phosphorylation is the α-subunit of eukaryotic translation 
initiation factor-2 (eIF2α) (179-181). Besides being positively regulated by ds-RNA and 
PACT/Rax, PKR can be negatively regulated by its cellular inhibitor, P58, a member of 
the tetratricopeptide (TPR) family of proteins (182). P58 is activated upon influenza virus 
infection (183) and capable of inhibiting PKR activation and eIF-2α phosphorylation by 
direct interaction with PKR and blocking PKR’s dimerization (184). 
The eIF2 is a three-subunit protein composed of α-, β- and γ-subunits with 
different molecular masses and is required in the first step of initiation of protein 
synthesis (185). The function of eIF2α is to mediate the binding of the initiator tRNA, 
Met-tRNAi, to the 40S-ribosomal subunit as a complex in a GTP-dependent manner 
(186). Upon joining to the 60S ribosomal subunit, GTP is hydrolyzed and eIF2 is released 
as eIF2·GDP. Prior to joining Met-tRNAi for another round of initiation, the GDP in eIF2 
must be exchanged for GTP. This guanine nucleotide exchange (GNE) reaction is 
catalyzed by eIF2B (187;188). When PKR phosphorylates eIF2α at serine-51, it converts 
eIF2 from a substrate to an inhibitor of its guanine nucleotide exchange factor, eIF2B 
(189). This reduction in recycling of eIF2 by eIF2B leads to inhibition of translation 
initiation (190). Phosphorylation of the -subunit in eIF2 occurs in cells or in cell-free 
translational systems in response to various stimuli, such as ethanol (191), heme-
deficiency, viral infection or low levels of double-stranded RNA, amino acid and nutrient 
starvation, purine limitation, serum and growth factor deprivation, transient transfection 
of certain plasmids, cerebral ischemia, exercise, heat shock, heavy metals, and release of 
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calcium from the endoplasmic reticulum (ER) or ER-stress (192). Several eIF2α kinases 
have been reported and each of them reponds to different stimuli. These include heme-
regulated kinase (HRI) activated by hemin depriviation (193), double-stranded RNA-
induced protein kinase (PKR) by ds-RNAnd PACT/Rax (194), GCN2 kinase from yeast 
(195), Drosophila and mouse (196;197) by amino acids and sereum starvation, and PKR-
like ER kinase (PERK) by ER-stress (198). All these kinases can lead to eIF2α 
phophorylation and translation initiation inhibition (199). 
2.3    Ethanol and protein synthesis  
  Protein synthesis is essential to sustain normal cellular functions. Previous studies 
have shown that ethanol significantly impairs brain growth (200), by decreasing the 
volume, weight and protein content in cerebellum of ethanol-exposed  pups (201-203). 
Ethanol feeding decreased the rate of protein synthesis in rats’ heart (204), liver (205) 
and skeletal muscle (206) by inhibiting peptide-chain initiation. Meanwhile, Wu (207) 
found that the protein synthesis inhibition induced by ethanol treatment can be partially 
reversed by adding purified eIF2 (included α, β and γ subunits) in rabbit reticulocytes. 
The phosphorylation of eIF2α can be increased up to 90% in rat hepatic cells after 
ethanol feeding (208). Furthermore, the reduction in protein synthesis induced by ethanol 
occurs through inhibition of protein synthesis initiation by blocking the ternary complex 
formation among eIF2α, GTP and initiator Met-tRNA rather than alteration in abundance 
of aminoacids or ribosomes (209). However no previous work has been done in the 
neuronal cells to elucidate whether eIF2α is involved in the mechanism of ethanol-
induced protein synthesis inhibition or the signaling pathway that leads to ethanol-
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Chapter Two: Glycogen Synthase Kinase 3β (GSK3β) Mediates 6-











 The causes of sporadic Parkinson’s disease (PD) are poorly understood.  6-
hydroxydopamine (6-OHDA), a PD mimetic, is widely used to model this 
neurodegenerative disorder in vitro and in vivo; however, the underlying mechanisms 
remain incompletely elucidated.  We demonstrated here that 6-OHDA evoked 
endoplasmic reticulum (ER) stress which was characterized by an up-regulation in the 
expression of GRP78 and GADD153 (Chop), the cleavage of procaspase-12, and 
phosphorylation of eukaryotic initiation factor-2α in human dopaminergic neuronal cell 
line (SH-SY5Y) and cultured rat cerebellar granule neurons (CGNs).  Glycogen synthase 
kinase-3β (GSK3β) responds to ER stress and its activity is regulated by phosphorylation.  
6-OHDA significantly inhibited phosphorylation of GSK3β at Ser9, whereas it induced 
hyperphosphorylation of Tyr216 with little effect on GSK3β expression in SH-SY5Y 
cells and PC12 cells (a rat dopamine cell line), as well as CGNs.  Furthermore, 6-OHDA 
decreased the expression of cyclin D1, a substrate of GSK3β, and dephosphorylated Akt, 
the upstream signaling component of GSK3β.  Protein phosphatase 2A (PP2A), an ER 
stress-responsive phosphatase, was involved in 6-OHDA-induced GSK3β 
dephosphorylation (Ser9).  Blocking GSK3β activity by selective inhibitors (lithium, 
TDZD-8 and L803-mts) prevented 6-OHDA-induced cleavage of caspase-3, poly(ADP-
ribose) polymerase (PARP), DNA fragmentations, and cell death.  With a tetracycline 
(Tet)-controlled TrkB inducible system, we demonstrated that activation of TrkB in SH-
SY5Y cells alleviated 6-OHDA-induced GSK3β dephosphorylation (Ser9) and 
ameliorated 6-OHDA neurotoxicity.  TrkB activation also protected CGNs against 6-
OHDA-induced damage.  On the other hand, antioxidants had little effect on 6-OHDA-
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induced GSK3β activation although they also offered neuroprotection.  These results 
suggest that GSK3β is a critical intermediate in pro-apoptotic signaling cascades that are 
associated with neurodegenerative diseases, thus providing a potential target site 




The endoplasmic reticulum is an intracellular compartment involved in calcium 
signaling and protein folding/processing.  Impaired function of the endoplasmic 
reticulum (ER), commonly referred to as ER stress, is usually caused by alterations in 
Ca2+ homeostasis, oxidative stress and accumulation of unfolded proteins.  ER stress is 
now known as an important factor in the neuropathology of a wide variety of 
neurological disorders (1-3).  Exemplary among these is Alzheimer’s disease (AD).  
Neurotoxic effects of amyloid β-peptides are at least partially targeted to the ER (4, 5).   
Recent genetic evidence indicates that ER stress is associated with Parkinson’s disease 
(PD) (6, 7). 
The molecular mechanisms of most neurodegenerative disorders remain elusive.  
For example, although some genetic and environmental factors have been identified as 
contributing to certain forms of PD, the etiology of this central nervous system disorder 
remains unknown (8, 9).  The hallmark of PD is a loss of dopaminergic neurons in the 
substantia nigra, which leads to clinical and pharmacological abnormalities characterizing 
the disease.  The majority of PD is sporadic, and the cause of neuronal death has not been 
defined.  Recent advances indicate that the excitotoxicity as well as the generation of 
reactive oxygen species (ROS) are important mediators of neuronal death in PD (10-12).  
It appears that these events involve mitochondrial abnormality.  However, downstream 
effectors in the death pathway have not been defined, nor is it clear whether 
mitochondrial events are the sole contributors to neuronal death in PD and other 
neurodegenerative diseases.  Recent studies point to ER stress as a potential mediator of 
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pathogenesis of PD.  The research using drug models suggests that PD mimetics induce 
ER stress in cultured neurons (13, 14). 
 Much PD research relies on drug models that mimic the selective dopaminergic 
neuron degeneration that occurs in this disorder.  Agents widely used for this purpose 
include 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-pyridinium (MPP+) and 
rotenone.  6-OHDA is a selective catecholaminergic neurotoxin that is widely used to 
study mechanisms of cell death in dopaminergic neurons as well as other types of 
neurons (13, 15-18).  6-OHDA can be formed from dopamine by non-enzymatic 
hydroxylation in the presence of Fe2+ and H2O2 (19).  Endogenous 6-OHDA was detected 
in the brain and urine samples of patients suffering from PD (20-22), suggesting that this 
compound is involved in the pathogenesis of PD.  The cellular and molecular 
mechanisms by which 6-OHDA induces neuronal loss, however, are not clear.  Human 
dopaminergic neuronal cell line SH-SY5Y possesses many qualities of substantia nigra 
neurons (23), and is therefore widely used to study the death of dopaminergic neurons.  
In the present study, we demonstrate that 6-OHDA induces ER stress in SH-SY5Y cells, 
and subsequently activates glycogen synthase kinase 3β (GSK3β), an ER stress-
responsive component.  Furthermore, our study reveals that GSK3β plays a critical role in 








Materials and Methods 
Materials  
Tetracycline (Tet), thapsigargin (Tha), tunicamycin (Tun), LiCl, okadaic acid 
(OA), N-acetylcysteine (NAC), tert-butylhydroquinone (tBHQ) and 6-hydroxydopamine 
(6-OHDA) were obtained from Sigma Chemical Co. (St Louis, MO).  All of the 
antibodies except anti-actin and anti-p-GSK3β (Tyr216) were obtained from Cell 
Signaling Technology, Inc. (Beverly, MA).  The anti-actin antibody was purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA) and the anti-p-GSK3β (Tyr216) antibody 
was obtained from Oncogene Research Products (San Diego, CA).  Inhibitors of GSK3β 
(TDZD-8; L803-mts), glutathione monoethyl ester (GSH-MEE), Trolox (a derivative of 
vitamin E) and (–)-Epigallocatechin gallate (EGCG) were purchased from Calbiochem 
(La Jolla, CA).   
Cell culture and treatment 
SH-SY5Y cells and PC12 cells were obtained from ATCC.  SH-SY5Y cells were 
grown in Eagle’s MEM containing 10% fetal bovine serum (FBS), 2 mM L-glutamine 
and 25 µg/ml gentamicin at 37°C with 5% CO2.  PC12 cells were maintained in RPMI-
1640 medium containing 5% FBS, 10% horse serum, 100 units/ml penicillin and 100 
µg/ml streptomycin.  SH-SY5Y cells expressing inducible TrkB (TB3 and TB8 cells) 
were generated under the control of a Tet-repressible promoter element (24).  TrkB is a 
high affinity receptor for brain derived neurotrophic factor (BDNF).  Culture and 
treatment of TB3 and TB8 cells were previously described (24).   
Cerebellar granule neurons (CGNs) were also selected for this study because 6-
OHDA induces apoptosis in these neurons (17, 25-27).   Cultures of CGNs were created 
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using a previously described method (28, 29).  Sprague Dawley rats were obtained from 
Hilltop Laboratory Inc. (Scottdale, PA).  Briefly, cerebella were obtained from 7-day-old 
rat pups, minced with a sterile razor blade, and suspended in 10 ml of trypsin solution 
(0.025%) at 37°C.  After incubation for 15 min, an equal volume of solution containing 
DNAse (130 Knuitz units/ml) and trypsin inhibitor (0.75 mg/ml) were added and the 
tissue was sedimented by a brief (5 seconds) centrifugation.  The tissue was dissociated 
by trituration, and the cell suspension was centrifuged through a 4% bovine serum 
albumin solution.  The cell pellet was re-suspended in Eagle’s MEM containing the 
following supplements: 10% FBS, 25 mM KCl, 1 mM glutamine, 33 mM glucose, and 
penicillin (100 units/ml)/streptomycin (100 µg/ml).  Cells (seeding density of 3.2-6.4 x 
104/cm2) were plated into poly-D-lysine (PDL, 50 µg/ml)-coated culture wells or dishes.  
Cells were incubated at 37ºC in a humidified environment containing 5% CO2 for at 
least 24 hours before initiating 6-OHDA treatment.  For blocking GSK3β activity, cells 
were treated with LiCl (222), TDZD-8 (10 µM) or L803-mts (5-20 µM) for 30-60 




MTT assay: The MTT assay was employed to determine the number of viable 
cells in culture (Roche Molecular Biochemicals. Indianapolis, IN) as previously 
described (30).  The assay is based on the cleavage of the yellow tetrazolium salt MTT 
[3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide] to purple formazan 
crystals by metabolically active cells.  Briefly, the cells were plated into 96-well 
microtiter plates and exposed to 6-OHDA (0 or 50 µM) for 48 h.  Following 6-OHDA 
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exposure, 10 µl of MTT labeling reagent were added to each well and the plates were 
incubated at 37ºC for 4 h.  The cultures were then solubilized and spectrophotometric 
absorbance of the samples was detected by a microtiter plate reader.  The wavelength to 





Accumulation of DNA fragments in the cytoplasm of apoptotic cells was 
determined by ELISA (Roche Molecular Biochemicals).  We have demonstrated that this 
measurement was sensitive to quantify neuronal apoptosis and was consistent with other 
morphometric indices of apoptosis (29, 31).  Briefly, the cells were maintained in 96-well 
plates.  After treatment, the cultures were washed twice with 0.01 M PBS, and the 
cultured cells were lysed.  Twenty microliters of cell lysate from each well were mixed 
with 80 µl of antibody solution in the coated wells.  The loaded wells were incubated at 
room temperature for 2 h.  Substrate was added to each well after it was washed three 
times in incubation buffer.  After incubation at room temperature for 10-20 min, the 
optical density was measured using a microtiter plate reader with a light filter of 405 nm.  
The readings were used to measure the degree of apoptosis. 
 
Northern blot analysis 
 
 Total RNA was extracted from TB3 and TB8 cells cultured in either Tet-on or 
Tet-off conditions.  RNA isolation and hybridization were performed as described 
previously (32).   Thirty µg of total RNA for TrkB was eletrophoresed in 1.2% agarose-
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6% formaldehyde gels.  Gels were stained with 2 mg/ml ethidium bromide.  
Hybridization was performed with 32P-labeled insert DNA isolated from a plasmid 
containing TrkB (33). 
 
Immunoblotting   
 
The immunoblotting procedure for detecting phosphorylation and expression of 
signal proteins was performed as previously described (34).  Briefly, cells were washed 
with PBS and lysed with RIPA buffer for 10 minutes, solubilized cells were centrifuged, 
the supernatant was collected, and the protein concentration was determined.  Aliquots of 
the protein (40 µg) were loaded onto the lanes of a sodium dodecylsulfate (SDS) 10% 
polyacrylamide gel.  The proteins were separated by electrophoresis, and the separated 
proteins were transferred to nitrocellulose membranes.  The membranes were blocked 
with either 5% nonfat dry milk or 5.0% BSA (for detection of phosphorylation) in 10 mM 
phosphate-buffered saline (pH 7.4) and 0.05% Tween-20 (TPBS) at room temperature for 
one hour to block non-specific immunoreactivity.  Subsequently, the membranes were 
incubated with primary antibodies directed against signaling proteins for 2 hours at room 
temperature or overnight at 4ºC.  After two quick washes in TPBS, the membranes were 
incubated with a secondary antibody conjugated to horseradish peroxidase (Amersham, 
Arlington Hts. IL) diluted at 1:2000 in TPBS for 1 hour.  The immune complexes were 
detected by the enhanced chemiluminescence method (Amersham).  In some cases, the 





Differences among treatment groups were tested using analysis of variance 
(ANOVA).  Differences in which p was less than 0.05 were considered statistically 
significant.  In cases where significant differences were detected, specific post-hoc 





6-OHDA induces endoplasmic reticulum (ER) stress and apoptosis  
 ER stress, which is triggered by the loss of calcium homeostasis or an 
accumulation of unfolded/misfolded proteins in the ER lumen, is generally characterized 
by up-regulation of GRP78 and GADD153, phosphorylation of eukaryotic initiation 
factor-2 alpha (eIF2α) and cleavage of ER-specific procaspase-12 (5, 35-38).  6-OHDA 
exposure caused a significant increase in the expression of GRP78, GADD153 and the 
phosphorylation of eIF2α at Ser51 in SH-SY5Y cells (Fig. 2.1A), indicating the 
occurrence of ER stress.  Similarly, we observed a significant up-regulation of GRP78 
and GADD153, phosphorylation of eIF2α, and cleavage of procaspase-12 in primary 
cultures of cerebellar granule neurons (CGNs) (Fig. 2.1B).    Thapsigargin and 
tunicamycin are the most widely applied agents to experimentally induce ER stress (39, 
40).  Thapsigargin inhibits ER-associated Ca2+-ATPase and disrupts Ca2+ homeostasis 
(41).  On the other hand, tunicamycin is known to specifically inhibit N-glycosylation in 
the ER (5).  As positive controls, these ER stress inducers up-regulated expression of 
GRP78 and GADD153, phosphorylation of eIF2α, and cleavage of procapase-12 (data 
not shown).  Furthermore, 6-OHDA exposure decreased cell number regardless of serum 
content in the medium (Fig. 2.2A and 2.2B).  It was noted that 6-OHDA induced a 
decrease in cell number in the serum-containing medium which became more evident 
than in serum-free medium after day 2.  It is known that GSK3β activation can cause 
suppression of cell proliferation in addition to cell death.  SH-SY5Y cells were 
proliferating in serum-containing medium, but not in serum-free medium.  It was likely 
the more severe reduction of cell number that occurred in serum-containing medium was 
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a combined effect of 6-OHDA on cell proliferation and cell death.  Therefore, serum-free 
medium was selected for all subsequent experiments to eliminate the confounding effect 
of cell proliferation.  The alteration in cell number was accompanied by an increase in 
apoptosis that was quantified by DNA fragmentation (Fig. 2.2C).  6-OHDA-induced 
apoptosis was further verified by the evidence of caspase-3 activation and cleavage of 
poly(ADP-ribose) polymerase (PARP) (Fig. 2.2D).  Thapsigargin and tunicamycin also 
induced apoptosis of SH-SY5Y cells to an extent similar to that caused by 6-OHDA (Fig. 
2.2B and 2.2C).   
   
6-OHDA activates GSK3β 
GSK3β is a kinase that plays a pivotal role in numerous cellular functions ranging 
from glycogen metabolism and modulation of microtubule dynamics to the regulation of 
cell survival (42, 43).  A recent study indicates that ER stress may activate GSK3β by 
inducing dephosphorylation at Ser9 (39).  Since 6-OHDA induced ER stress, we sought 
to determine whether 6-OHDA could regulate GSK3β phosphorylation.  The activity of 
GSK3β is regulated negatively by the phosphorylation of serine 9 (Ser9) and positively 
by the phosphorylation of tyrosine 216 (Tyr216) (43).  As shown in Fig. 2.3A, 6-OHDA 
inhibited phosphorylation of GSK3β at Ser9, whereas it stimulated phosphorylation at 
Tyr216 in SH-SY5Y cells.  The effect of 6-OHDA on GSK3β phosphorylation 
diminished after 24 h of exposure.  6-OHDA had little effect on the expression of 
GSK3β.   PC12 cells are a rat dopamine cell line that has been extensively used for 
studying the mechanism of PD mimetic–induced damage.  As shown in Fig. 2.3B, 6-
OHDA also induced dephosphorylation of GSK3β at Ser9 without affecting its 
expression levels in PC12 cells.  Similarly, 6-OHDA-mediated dephosphorylation of 
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GSK3β at Ser9 was observed in cultured CGNs (Fig. 2.3C).  Akt is one of the most 
important upstream signaling components that regulate GSK3β phosphorylation at Ser9 
(43).   6-OHDA also induced a transient inhibition of Akt phosphorylation at Ser473 in 
SH-SY5Y cells, PC12 cells and CGNs (Fig. 2.3).  Cyclin D1 is a substrate of GSK3β; 
phosphorylation of cyclin D1 by GSK3β facilitates an ubiquitin-dependent degradation of 
cyclin D1 (44, 45).  6-OHDA down-regulated cyclin D1 in SH-SY5Y cells and PC12 
cells (Fig. 2.3D), indicating the activation of GSK3β.  For a comparison, two ER stress 
inducers (thapsigargin and tunicamycin), also dephosphorylated GSK3β at Ser9 in a 
similar pattern (Fig. 2.3E).  It has been demonstrated that ER stress-induced GSK3β 
dephosphorylation (Ser9) is mediated by PP2A in SH-SY5Y cells (39).  We sought to 
determine whether PP2A was involved in 6-OHDA-mediated GSK3β dephosphorylation.  
As shown in Fig. 2.4, blocking PP2A activity by okadaic acid (1 nM) eliminated 6-
OHDA-mediated GSK3β dephosporylation (Ser9).  At concentrations less than 5 nM, 
okadaic acid specifically blocks PP2A activity without affecting PP1 (46). 
  
6-OHDA-induced cell death is mediated by GSK3β. 
 It has been recently recognized that GSK3β is an important modulator of 
apoptosis (42, 43).  To determine whether 6-OHDA-induced neuronal apoptosis was 
mediated by GSK3β, we blocked GSK3β activity by pre-incubating SH-SY5Y cells with 
lithium, a widely used selective GSK3β inhibitor (47), or a synthetic chemical GSK3β 
inhibitor (TDZD-8).  TDZD-8 has been shown to specifically inhibit GSK3β activity with 
little effect on other kinases (47).  After pre-treatment with GSK3β inhibitors, SH-SY5Y 
cells were exposed to 6-OHDA and cell death was evaluated.  As shown in Figs. 2.5A 
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and 2.5B, pretreatment with TDZD-8 eliminated 6-OHDA-induced cell death as 
measured by cell viability (MTT assay) and apoptosis (DNA fragmentation ELISA).  
Lithium also significantly rescued SH-SY5Y cells from 6-OHDA-induced cell death.  
Furthermore, TDZD-8 and lithium blocked 6-OHDA-mediated caspase-3 activation and 
cleavage of PARP (Fig. 2.5C), which confirmed the neuroprotective effect of GSK3β 
inhibitors.  Similarly, neuroprotection by TDZD-8 and lithium against 6-OHDA-induced 
damage was observed in cultured CGNs (Fig. 2.5D).  Involvement of GSK3β in 6-
OHDA-induced cell death was further verified using a novel cell-permeable peptide 
inhibitor of GSK3β (L803-mts).  L803-mts is a substrate-specific, competitive 
phosphorylated peptide inhibitor of GSK3β.  This inhibitor is shown to selectively block 
GSK3β activity without affecting the activity of other kinases (48).   L803-mts 
significantly protected SH-SY5Y and PC12 cells against 6-OHDA-induced cell death in a 
concentration dependent manner (Fig. 2.5E).  Only 5 and 10 µM were used in SH-SY5Y 
cells because L803-mts was cytotoxic for these cells at the concentrations ≥ 20 µM.  
L803-mts blocked 6-OHDA-induced down-regulation of cyclin D1 (Fig. 2.5F), indicating 
that this peptide effectively inhibited GSK3β activity.  
 
 
TrkB activation induces GSK3β phosphorylation and protects neuronal cells from 6-
OHDA-induced death 
 The survival, differentiation and function of neurons are regulated by a family of 
growth factors called neurotrophins (NTs), which includes nervous growth factor (NGF), 
brain derived neurotrophic factor (BDNF), NT-3 and NT-4/5 (49).  The effects of NTs 
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are mediated by the tyrosine kinase receptor of the Trk family at the cytoplasmic 
membrane (TrkA, TrkB and TrkC).  BDNF binds to TrkB and initiates a number of anti-
apoptotic signaling pathways including phosphatidylinositol 3-kinase (PI3K)/Akt 
pathway (24, 49, 50).  Activated Akt promotes GSK3β phosphorylation at Ser9 resulting 
in its inhibition (43).  SH-SY5Y cells express low levels of TrkB and barely respond to 
BDNF.  With a Tet-regulated inducible TrkB expression system (TB8 and TB3 cells), we 
were able to determine whether TrkB activation can override 6-OHDA-mediated GSK3β 
dephosphorylation (Ser9) and provide protection against 6-OHDA-induced cell death.  In 
the Tet-off condition (no Tet in culture medium), TrkB expression was induced in both 
TB8 and TB3 cells (derivatives of SH-SY5Y cells)(Fig. 2.6A).  Activation of TrkB by 
BDNF in Tet-off TB8 cells induced phosphorylation of GSK3β at Ser9, which 
presumably inhibits the activation of GSK3β (Fig. 2.6B).  Furthermore, BDNF alleviated 
6-OHDA-induced GSK3β dephosphorylation (Ser9) in TB8 cells expressing high TrkB 
(Tet-off condition, Fig. 2.6C), but not in a Tet-on condition (data not shown).  More 
importantly, BDNF significantly ameliorated 6-OHDA-induced cell death in Tet-off TB8 
cells; however, it was ineffective at protecting TB8 cells in a Tet-on condition (Figs. 
2.7A and 2.7B).  A similar result was observed with TB3 cells (data not shown).   
Similarly, BDNF significantly protected CGNs from 6-OHDA-induced cell death (Fig. 
2.5D); these cells are known to express TrkB, but not TrkA (51).  6-OHDA neurotoxicity 
may be mediated by oxidative stress.  To determine whether oxidative stress was 
involved in 6-OHDA-induced GSK3β activation, we examined the effect of various 
antioxidants on 6-OHDA-induced cell death and GSK3β activation.  As shown in Fig. 
2.8A, these antioxidants offered significant neuroprotection against 6-OHDA-induced 
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cell death.  However, none of these antioxidants significantly affected 6-OHDA-mediated 
GSK3β dephosphorylation (Ser9).  Results obtained from the treatment of NAC and 





The mimetics of Parkinson’s disease (PD), such as 6-hydroxydopamine (6-
OHDA), 1-methyl-4-phenyl-pyridinium (MPP+) and rotenone have been widely used to 
model this neurodegenerative disorder.  However, the mechanisms mediating their 
activation of a neurodegenerating program remain incompletely elucidated.  We 
demonstrate here that 6-OHDA, a PD mimetic, causes ER stress which is characterized 
by increase in ER chaperones and the phosphorylation of eIF2α.  6-OHDA induces cell 
death and activates apoptotic signaling, such as caspase-3 activation and cleavage of 
PARP.  These findings are supported by recent studies which show PD mimetics could 
induce unfolded protein response (UPR) and the expression of genes involved in ER 
stress response (13, 14).  More importantly, our study reveals that glycogen synthase 
kinase 3β (GSK3β) is a key intermediate for 6-OHDA-triggered apoptotic signaling; 
blocking GSK3β activity by selective inhibitors or by activation of TrkB eliminates 6-
OHDA-mediated caspase-3 activation, cleavage of PARP and DNA fragmentation.      
GSK3, a serine/threonine kinase originally identified as a regulator of glycogen 
metabolism, is also a central component of the Wnt signaling pathway important for 
proper axis formation during embryonic development (52).  There are two highly 
homologous forms of GSK3 in mammals, GSK3α and GSK3β.  GSK3β is particularly 
abundant in the central nervous system, where it is localized primarily in neurons (53).   
Recent studies indicate that cellular stress, such as ER stress, oxidative stress, heat shock 
and hyperosmotic stress, can modulate the activity of GSK3β (39, 43, 54).  GSK3 is 
unusual in that it appears to be largely regulated by inhibition.  One mean by which 
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GSK3β can be inactivated is through phosphorylation of Ser9.  Numerous kinases, such 
as Akt/protein kinase B (PKB), protein kinase C (PKC), p70 S6 kinase, p90Rsk and 
protein kinase A (PKA) can phosphorylate GSK3β at Ser9 and therefore inactivate 
GSK3β (42, 43).  GSK3β is also capable of being regulated by an activation pathway.  
Activation of GSK3β is accomplished by phosphorylation at Tyr216; research on 
mechanisms of phosphorylation of GSK3β at Tyr216 is relatively sparse.  Available 
evidence indicates that phosphorylation at Tyr216 can be regulated by alterations in 
intracellular calcium levels or by Fyn, a member of the Src tyrosine kinase family (55, 
56). 
Our study shows that 6-OHDA induces GSK3β dephosphorylation (Ser9).  It has 
been reported that cellular stress, such as ER stress or hyperosmotic stress, can activate 
protein phosphatase 2A and 2B (PP2A and PP2B) (39, 46, 54).  PP2A is known to 
dephosphorylate Akt and GSK3β at Ser9 (57-59).  Induction of ER stress by thapsigargin 
and tunicamycin dephosphorylates GSK3β at Ser9; blocking PP2A activation eliminates 
ER stress-mediated dephosphorylation (39).  Similarly, our results show that blockage of 
PP2A abolishes 6-OHDA-induced GSK3β dephosphorylation, suggesting that the 
alteration in GSK3β phosphorylation results from ER stress.  6-OHDA increases GSK3β 
phosphorylation at Tyr216; this may involve an alteration in the intracellular calcium 
concentration since it has been shown that 6-OHDA can change the expression of 
calcium binding proteins and disrupt intracellular calcium homeostasis (60-62).  As 
mentioned above, calcium homeostasis is a key mediator of GSK3β phosphorylation at 
Tyr216 (55). 
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The ER is an intracellular compartment that plays an important role in the 
maintenance of Ca2+ homeostasis and proper folding of newly synthesized membranous 
and secretory proteins (2).   Conditions associated with ER dysfunction induce highly 
conserved stress responses.  These include the unfolded protein response (UPR), the ER 
overloaded response (EOR) and the ER-associated degradation (ERAD) (63).  
Accumulating evidence indicates that ER stress may be a common denominator for acute 
brain injury (e.g., cerebral ischemia) and chronic degenerative diseases (e.g. Alzheimer’s 
disease and Parkinson’s disease) (2, 42).  However, the mechanisms underlying ER 
stress-triggered neurodegeneration are unclear.  We demonstrate that dopaminergic cells 
(SH-SY5Y and PC12 cells) and glutamatergic neurons (cerebellar granule neurons) 
display a similar response to 6-OHDA, suggesting that 6-OHDA-evoked ER-stress and 
the activation of GSK3β may not be restricted to dopaminergic neurons.  It has been 
suggested that 6-OHDA-evoked neuronal apoptosis is independent of cell type and does 
not require a dopamine transporter (64).  More importantly, our results link PD mimetic-
evoked ER stress to GSK3β activation, providing an important insight into the 
relationship between ER stress and degenerative diseases.   
A growing body of evidence suggests that GSK3β is an important modulator of 
apoptosis.  It appears that GSK3β activity correlates inversely with neuronal viability (39, 
65-67).   For example, over-expression of GSK3β in specific regions of the brain in adult 
mice results in neuronal death in these regions (67).  Neuronal apoptosis induced by 
trophic withdrawal also appears mediated by GSK3β activation (66).  GSK3β has been 
directly linked to several key neuropathological mechanisms of Alzheimer’s disease 
(AD) (42, 68).  The mechanisms by which GSK3β facilitates apoptosis have yet to be 
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identified.  GSK3β has a broad spectrum of substrates.  One, and perhaps the most 
important mechanism, is that it inhibits activation of many transcription factors.  Several 
transcription factors that are known targets of GSK3β regulate cell survival.  These 
include NFAT, HSF-1, CREB, AP-1 and NF-кB (42, 43).  Furthermore, recent evidence 
suggests that subcellular redistribution of GSK3β to the nucleus may also trigger a 
proapoptotic signaling cascade (69). 
Under physiological conditions, 6-OHDA can be oxidized to generate reactive 
oxygen species (ROS) and many neurotoxic effects of 6-OHDA are believed to be 
mediated by oxidative stress (70-75).  Various antioxidants, such as NAC, tBHQ, GSH, 
EGCG, have been previously shown to protect neuronal cells against 6-OHDA-induced 
cell death (71-75).  Consistent with these findings, we show here that antioxidants offer 
significant neuroprotection; however, these antioxidants have little effect on 6-OHDA-
mediated GSK3β dephosphorylation.  This result suggests that oxidative stress is 
minimally involved in the ER stress-GSK3β pathway.   
Selective GSK3β inhibitors eliminate 6-OHDA neurotoxicity in these neuronal 
cells, indicating that GSK3β is a key component of the proapoptotic signaling cascade.  
Neurotrophic factors, such as glial cell line-derived neurotrophic factor (GDNF) and 
brain-derived neurotrophic factor (BDNF), are promising agents for neuroprotective 
therapies.  The GDNF receptor is distributed in the substantia nigra (SN) neurons, and its 
neuroprotective action is mainly mediated by the PI3K/Akt pathway (76-79).  A recent 
study demonstrates that GDNF significantly mitigates 6-OHDA-induced chromatin 
condensation and DNA fragmentation in a dopaminergic MN9D cell line; the 
neuroprotection is mediated by the PI3K/Akt pathway (79).  Akt is up-stream of GSK3β, 
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and its activation results in an inhibition of GSK3β.  It is likely, therefore, that GSK3β is 
involved in GDNF-mediated neuroprotection.  Neurotrophin receptors (TrkA, TrkB and 
TrkC) regulate neuronal survival; activation of TrkB causes enhanced Akt activity (24, 
80-82).  TrkB is expressed in the SN neurons (83, 84).  The activation of TrkB is shown 
to promote the survival of the SN neurons and protect the SN neurons against excitotoxic 
insult (85, 86).  Our results show that activation of TrkB can override 6-OHDA-mediated 
GSK3β dephosphorylation (Ser9) and protect neurons against 6-OHDA-induced damage.  
These results suggest that neuroprotection provided by growth factors/neurotrophins or 
GSK3β inhibitors may share the same mechanism, that is, the modulation of a common 
intermediate, GSK3β.  Therefore, the development of selective and safe GSK3β 
inhibitors may provide a therapeutic benefit in alleviating or slowing down the 








Figure 2. 1  6-OHDA-induced ER stress 
  (A) SH-SY5Y cells were cultured in serum-free medium for 24 h.  Cells were exposed 
to 6-OHDA (0 or 50 µM).  The expression of GRP78, GADD153 and phosphorylation of 
eIF2α (Ser51) were determined by immunoblots.  (B) CGNs were isolated from 7-day-
old rat pups, maintained in serum-free medium and exposed to 6-OHDA (50 µM). The 
expression of GRP78, GADD153, procaspase-12 and phosphorylation of eIF2α were 
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Figure 2. 2  6-OHDA-induced apoptosis of SH-SY5Y cells  
(A) Cells were exposed to 6-OHDA (0 or 50 µM) and the number of viable cells was 
determined by MTT assay as described under the Materials and Methods.  6-OHDA-
mediated alterations were expressed as a percentage of the control.  (B) Cells were 
exposed to 6-OHDA (DA, 50 µM), thapsigargin (Tha, 1 µM) and tunicamycin (Tun, 3 
µg/ml) for 30 h and a relative number of viable cells was determined.  Each data point 
represents the mean ± SEM of five replications.  * p < 0.05, statistically significant 
differences between the controls and 6-OHDA- or Tha/Tun-treated cultures.  (C) 
Quantification of apoptosis with DNA fragmentation ELISA.  Cells were exposed to 6-
OHDA (DA, 50 µM), thapsigargin (Tha, 1 µM) and tunicamycin (Tun, 3 µg/ml) for 30 h.  
Relative apoptosis was determined with DNA fragmentation ELISA as described under 
the Materials and Methods.  Each data point represents the mean ± SEM of four 
replications.  * p < 0.05, statistically significant differences between the controls and 6-
OHDA- or Tha/Tun-treated cultures.  (D) Activation of caspase-3 and cleavage of PARP.  
Cells were exposed to 6-OHDA (50 µM) and the expression of active (cleaved) caspase-3 
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Figure 2. 3  Effect of 6-OHDA on GSK3β, Akt and Cyclin D1 
 (A) SH-SY5Y cells were cultured in serum-free medium for 24 h and exposed to 6-
OHDA (50 µM).  Phosphorylation and expression of GSK3β and Akt were determined 
by immunoblots.  The same blots were stripped and re-probed with an anti-actin antibody 
(Panel on the left).  The relative amount of phosphorylated proteins imaged on the films 
was measured microdensitometrically using SigmaGel software (SPSS, Chicago IL) 
(Panel on the right).  Each data point (± SEM; bars) is the mean of three replicates.  (B) 
PC12 cells were cultured in serum-free medium for 24 h and exposed to 6-OHDA (50 
µM).  The phosphorylation and expression of GSK3β and Akt were determined by 
immunoblots.  (C) Cerebellar granule neurons (CGNs) were isolated from 7-day-old rat 
pups, maintained in serum-free medium and exposed to 6-OHDA (50 µM).  
Phosphorylation and expression of GSK3β and Akt were determined by immunoblots.  
(D) SH-SY5Y and PC12 cells were cultured in serum-free medium for 24 h and exposed 
to 6-OHDA (50 µM).  The expression of cyclin D1 was determined by immunoblots.  
The same blots were stripped and re-probed with an anti-actin antibody.  The experiment 
was replicated three times.  (E) SH-SY5Y and PC12 cells were treated with thapsigargin 
(Tha, 1 µM) or tunicamycin (Tun, 3 µg/ml) for 1-12 h.  Phosphorylation (Ser9) and 





Figure 2. 4  Effect of inhibitor of PP2A/PP1 on 6-OHDA-mediated GSK3β 
dephosphorylation 
SH-SY5Y cells were cultured in serum-free medium and pre-treated with a selective 
inhibitor of PP2A/PP1, okadaic acid (OA, 0 or 1 nM), for 30 min.  After that, cells were 
exposed to 6-OHDA (50 µM), and phosphorylation of GSK3β (Ser9) was determined by 
immunoblots.  The same blots were stripped and re-probed with an anti-actin antibody 
(Top panel).  The relative amount of phosphorylated proteins imaged on the films was 
  59






0     1     2     6    12  1     2     6    12  1      2     6    12  
6 - OHDA 6 - OHDA+Li 6 - OHDA+GSKi 
PARP 
116  kD 
85  kD 























































Figure 2. 5  Effect of inhibitors of GSK3β on 6-OHDA-mediated cell death 
 (A) SH-SY5Y cells were cultured in serum-free medium and pre-treated with inhibitors 
of GSK3β, LiCl (Li, 20 mM) or TDZD-8 (10 µM) for 1 h.  After that, cells were exposed 
to 6-OHDA (DA, 50 µM, 24 h) and the numbers of viable cells were determined by the 
MTT assay.  The amount of cells relative to the untreated control was calculated.  (B) 
SH-SY5Y cells were similarly treated as described in (A) and relative apoptosis was 
determined as described in Figure 1.2.  Each data point (± SEM; bars) is the mean of four 
independent trials.  * p < 0.05, statistically significant difference from untreated controls.   
(C) Expression of PARP and active (cleaved) caspase-3.   SH-SY5Y cells were similarly 
treated as described in (A) and the expression of PARP and active caspase-3 was 
determined as described in Figure 1.2.  The experiment was replicated three times.  (D) 
CGNs were pretreated with BDNF (100 ng/ml, 24 h) or inhibitors for GSK3β (Li or 
TDZD-8, 1h).  After that, cells were exposed to 6-OHDA (50 µM) for 24 h.  The number 
of viable cells was determined with MTT assay and the amount of cells relative to the 
untreated control was calculated.  Each data point (± SEM; bars) is the mean of four 
independent trials.  * p < 0.05, statistically significant difference from untreated controls.  
** p < 0.05, statistically significant difference from 6-OHDA-treated groups.  (E) SH-
SY5Y and PC12 cells were cultured in serum-free medium and pre-treated with a cell-
permeable peptide inhibitor of GSK3β (L803-mts, 0-20 µM) for 1 h.  After that, cells 
were exposed to 6-OHDA (50 µM) and the number of viable cells was determined by 
MTT assay.  Each data point (± SEM; bars) is the mean of four independent trials.  * p < 
0.05, statistically significant difference from 6-OHDA only groups.  (F)  SH-SY5Y cells 
were pre-treated with L803-mts (0 or 15 µM) for 1 h, and exposed to 6-OHDA (50 µM).  
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The expression of cyclin D1 was determined by immunoblots (Top panel).  The same 
blots were stripped and re-probed with an anti-actin antibody.  The relative amount of 
cyclin D1 was measured microdensitometrically and normalized to the expression of 
actin (Bottom panel).  The experiment was replicated three times.  
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Figure 2. 6  BDNF-induced GSK3β phosphorylation in SH-SY5Y cells 
(A) Inducible expression of TrkB in SH-SY5Y cells. TB8 and TB3 cells were cultured 
for 3 days in the presence or absence of Tet (1 µg) in a medium containing 10% FBS.  
Total RNA was extracted, and 30 µg of total RNA was electrophoresed in a 1.2% 
agarose/formaldehyde gel and stained with 2 mg/ml ethidium bromide.  Gels were 
subsequently transferred to a nitrocellulose membrane, and hybridized with a 32P-labeled 
cDNA probe for TrkB.  (B) BDNF induced phosphorylation of GSK3β at Ser9.  TB8 
cells expressing high levels of TrkB (Tet-off condition) were cultured in serum-free 
medium and exposed to BDNF (100 ng/ml).  Phosphorylation and expression of GSK3β 
were determined with immunoblots.  The same blots were stripped and re-probed with an 
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anti-actin antibody.  (C) Counteracting 6-OHDA’s effect by BDNF.  TB8 cells 
maintained in a Tet-off condition were pre-treated with BDNF (0 or 100 ng/ml) for 24 h.  
After pre-treatment, cells were exposed to 6-OHDA (50 µM) with/without BDNF for 2 h.  













































Figure 2. 7  Effect of TrkB activation on 6-OHDA-mediated cell death  
TB8 cells were cultured for 3 days in the presence or absence of Tet (Tet-on or Tet-off, 1 
µg).  Cells were then pre-treated with BDNF (0 or 100 ng/ml) for 24 h and exposed to 6-
OHDA (DA, 50 µM) for an additional 24 h.  Relative apoptosis (A) and the number of 
viable cells (B) were determined as described in Figure 2.  Each data point (± SEM; bars) 
is the mean of four independent trials.  * p < 0.05, statistically significant difference from 
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Figure 2. 8  Effect of antioxidants on 6-OHDA-induced cell death and GSK3β 
lls grown in serum-free medium were pre-treated with various 
dephosphorylation 
 (A) SH-SY5Y ce
antioxidants for 30 min, and exposed to 6-OHDA (50 µM) for 24 h.  Cell viability was 
analyzed with MTT assay.  The experiment was replicated four times.  * p < 0.05, 
statistically significant difference from 6-OHDA-treated but no antioxidant-exposed 
groups.  ** p < 0.05, statistically significant difference from paired, antioxidant-treated 
but no 6-OHDA-exposed groups.  NAC (N-acetylcysteine, 10 mM); GSH-MEE 
(glutathione monoethyl ester, 8 mM); tBHQ (tert-butylhydroquinone, 40 µM); Trolox (10 
µM); EGCG [(–)-Epigallocatechin gallate, 1 µM]; Ct (control, ddH2O).  (B, C) SH-SY5Y 
cells grown in serum-free medium were pre-treated with NAC (223) or GSH-MEE (8 
mM) for 30 min, and exposed to 6-OHDA (50 µM).  Phosphorylation (Ser9) and 
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Abstract 
     
Early developmental exposure to ethanol causes profound damage to the 
cerebellum, specifically significant reduction in cerebellar volume, weight and protein 
content. PACT (Rax) / PKR / eIF2α is an important signal transducting pathway which 
controls the protein synthesis initiation response to different stimuli. Previous studies 
have shown that ethanol exposure decreases the protein content in rat cerebellum and 
inhibits protein synthesis initiation in rat heart, liver and skeletal muscle. Here we 
demonstrate that the expressions of PACT (Rax) / PKR / eIF2α are developmentally 
regulated in rat cerebellum as ethanol exposure promotes the association of PACT (Rax) 
with PKR. Ethanol-induced interaction between PACT (Rax) and PKR leads to 
phosphorylation of eIF2α and protein synthesis initiation inhibition. This inhibition can 
be enhanced by the over-expression of PACT (Rax). The effect of ethanol can be 
reversed by a mutated PACT (Rax) gene at serine 18 or PKR inhibitors. Our results 





Ethanol is wildly known as a teratogen (1-3); early exposure to ethanol will cause 
a variety of behavioral and neural abnormalities (4-6). In some cases of pregnant women, 
heavy chronic ethanol consumption during fetus central nervous system (CNS) causes 
fetal alcohol syndrome (FAS) characterized by microcephaly (7), facial dysmorphology 
(8), growth retardation (9) and a number of CNS abnormalities (10-12) in newborns. The 
developing cerebellum is one of the most vulnerable regions to ethanol in both humans 
and animals (13;14). Numerous animal model systems have been used to characterize this 
kind of CNS abnormality. One of these studies showed that growth of the rat brain, but 
not body growth, was decreased and the cerebellar was inhibited twice as much compared 
with the rest of the brain after exposure to ethanol (15). Other studies showed that ethanol 
exposure in rat pups led to significant reduction in cerebellar volume, weight (16) and 
protein content (17). The molecular mechanism(s) for ethanol’s involvement in decreased 
cerebellum size and inhibition of protein synthesis has not been fully elucidated. 
Previous work has determined that ethanol exposure decreased protein synthesis 
in rat heart (18;19), liver (20) and skeletal muscle (21), as well as in rabbit reticulocytes 
(22). Furthermore, ethanol-induced protein synthesis inhibition occurs by blocking the 
ternary complex formation among eIF2α, GTP and initiator Met-tRNA in protein 
synthesis initiation, rather than by alterations in availability of amino acids or abundance 
of ribosomes (23). The phosphorylation of eIF2α can be increased up to 90% in rat 
hepatic cells after ethanol treatment (24). However, the signal transduction pathway(s) 
that lead to inhibition of the protein synthesis initiation and eIF2α phosphorylation 
remain unclear. 
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Double-stranded RNA (dsRNA) activated protein kinase (PKR) is a 
serine/threonine protein kinase and is ubiquitously expressed in mammalian cells. It 
contains 551 amino acids in humans and 515 in mice (25;26). PKR consists of two 
functionally distinct domains: an N-terminal dsRNA binding regulatory domain and the 
C-terminal catalytic domain (27-31). PKR is initially identified as an interferon-induced 
protein that is activated in virus-infected cells by double-stranded RNA produced during 
the virus life cycle (32;33). Recently it has been clear that PKR is a component of signal 
transduction pathways mediating important cellular functions such as growth control, 
proliferation, differentiation and stress response (34-36). PKR can be activated by 
dsRNA, cytokines (37),  growth factor, serum deprivation, bacterial products or 
physiochemical stress (38;39). A pair of dsRNA binding motifs located in the N-terminal 
domain of PKR act as a sensor to bind dsRNA or protein activators (which themselves 
contain dsRNA binding domains) (40). The known protein activators of PKR include 
PACT (PKR-activating protein) (41-43) and its mouse homologue Rax (44). PACT/Rax 
is also a ubiquitously expressed mammalian protein which is phosphorylated at serine 18 
following stress; it heterodimerizes with PKR and activates it in absence of dsRNA (45). 
Serine 18 of PACT/Rax is a crucial phosphorylation site for activation of PKR. The 
serine 18 mutated PACT/Rax can still associate with PKR, but it loses its kinase activity 
(46). Upon dsRNA or PACT/Rax binding, PKR undergoes a conformational change, 
which results in dimerization and autophosphorylation at Thr-446 and Thr-451 (47-51). 
Once activated, PKR phosphorylates its substrates down stream; the α-subunit of 
eukaryotic translation initiation factor-2 (eIF2α) is the main substrate of PKR (52;53). 
While PKR can be positively regulated by ds-RNA and PACT/Rax, it can also be 
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negatively regulated by its cellular inhibitor, P58, a member of the tetratricopeptide 
(TPR) family of proteins (54). P58 is activated upon influenza virus infection (55). It is 
capable of inhibiting PKR activation and eIF2α phosphorylation by direct interaction 
with PKR, blocking PKR dimerization (56). 
The eukaryotic translation initiation factor-2 (eIF2) is required in the first step of 
initiation in protein synthesis. It is composed of α-, β- and γ-subunits (57;58). The 
function of eIF2α is to mediate the binding of the initiator tRNA and Met-tRNAi, to the 
40S-ribosomal subunit as a complex in a GTP-dependent manner (59). When PKR 
phosphorylates eIF2α at serine-51, it converts eIF2 from a substrate to an inhibitor of its 
guanine nucleotide exchange factor, eIF2B (60). This reduction in recycling of eIF2 by 
eIF2B leads to inhibition of translation initiation (61). Phosphorylation of the α-subunit in 
eIF2 occurs in cells or in cell-free translational systems in response to various stimuli, 
including ethanol (62). The present study is designed to explore the mechanism(s) of 
ethanol-induced protein synthesis inhibition in neural systems in vitro and in vivo. Our 
results show that ethanol activates eIF2α and leads to protein synthesis inhibition, at least 
in part, via PACT/Rax-PKR-eIF2α signal transducting pathway.   
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Two kinds of PKR inhibitors were used, 2-Aminopurine (2-Ap) was purchased 
from Sigma (St. Louis, MO) and PKR inhibitor was purchased from EMD Biosciences 
(Darmstadt, Germany). 
Animal surgeries and tissue collection 
 
For non-ethanol treatment: Sprague-Dawley rats were obtained from Harlan-
Sprague-Dawley (Indianapolis, IN, USA). The animals were maintained in a temperature 
/ humidity controlled facility with a 12-h light / dark cycle. All animal protocols were 
approved by the ACUC of West Virginia University and complied with the NIH 
guidelines for animal care and use. The number of animals represented a minimal but 
adequate number for statistical analysis. Cerebellar tissues were collected from pups on 
the designed postnatal days. Pups were anesthetized by injection of ketamine / xylazine 
and decapitated. Their cerebella were harvested by cutting through the cerebellar 
peduncles, frozen on dry ice, and stored at -80°C for further processing.   
For ethanol treatment: Long-Evans male and female breeders obtained from 
Simonsen Laboratory (Gilory, CA) and housed in the PUI vivarium, were placed together 
on designated evenings and allowed to mate overnight. Gestational day (GD) 0 was 
defined as the first morning that sperm was detected on a vaginal smear after overnight 
mating. GD 22 was designated as PD 0, and more than 80% of births occurred on GD 
22. Rats born on GD 21 were considered PD 0 the following day and rats born on GD 
23 were considered PD 1 on that day. Pups were identified by a code, using a permanent 
tattoo on one or more paw, produced by subcutaneous injection of a small amount of 
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nontoxic black ink (performed prior to group assignment). Fourteen pups were assigned 
to two groups. There were two kinds of treatment in each group, intubated with milk 
formula (control treatment) or a solution of 11.33% (v/v) ethanol in milk formula 
(ethanol treatment) in a volume of 0.03 ml/g body weight 3 times a day separated by 2 
hours. In group-1, eight pups were assigned to ethanol or control treatment (2 males and 
2 females each) on postnatal day 9 (PD9). In group-2, six pups were assigned to ethanol 
or control treatment (1 male and 2 females each) from PD4-9. After treatment, using the 
protocol described, previously collected cerebellum tissues were frozen on dry ice, and 
stored at -80°C for further processing. 




SH-SY5Y, SK-N-MC neuroblastoma and 293 human kidney cell lines were 
obtained from ATCC and grown in EMEM (DMEM for 293) containing 10.0% fetal 
bovine serum (FBS), 2.0 mM L-glutamine and streptomycin (100 µg/ml)/penicillin (100 
units/ml) at 37°C with 5.0% CO2.  
PKR+/+ and PKR-/- mouse embryonic fibroblasts (MEFs) were obtained from 
Dennis Baltzis at Lady Davis Institute for Medical Research, McGill University, Quebec, 
Canada and maintained in Dulbecco's modified Eagle's medium supplemented with 10% 
heat-inactivated fetal bovine serum and penicillin-streptomycin (100 units/ml) at 37°C 
with 5.0% CO2.     
Rax wild type and mutant plasmid: 
HA-tagged Rax constructs with wildtype or S18A mutation (substitute Serine to 
Alanine at site 18) were cloned into vector pcDEF3 which utilizes the EF-1α promoter. 
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Lipofectamine (Invitrogen) was used to transfect plasmids to SK-N-MC or 293 cells 
according to manufacturer’s protocol. Stable clones were selected in G418 (0.6 mg/ml) 
and screened by Western blotting with anti-HA antibody. 
Primary culture of cerebellar granule cells: 
Cultures of cerebellar granule cells (CGCs) were created using a previously 
described method (63). Briefly, cerebella were obtained from 7-day-old rat pups, and 
minced with a sterile razor blade and suspended in 10.0 ml of trypsin solution (0.025%) 
at 37°C.  After incubation for 15 min, an equal volume of solution containing DNAse 
(130 Knuitz units/ml) and trypsin inhibitor (0.75 mg/ml) was added and the tissue was 
sedimented by a brief (5 seconds) centrifugation.  The tissue was dissociated by 
trituration, and the cell suspension was centrifuged through a 4.0% bovine serum albumin 
solution, which is a critical step for increasing neuronal viability.  The cell pellet was re-
suspended in Eagle’s MEM containing the following supplements: 10.0% FBS, 25.0 mM 
KCl, 1.0 mM glutamine, 33.0 mM glucose, and penicillin (100.0 units/ml)/streptomycin 
(100.0 µg/ml).  Cells (seeding density of 3.2-6.4 x 104/cm2) were plated into poly-D-
lysine (PDL, 50.0 µg/ml)-coated culture wells or dishes and incubated at 37ºC in a 
humidified environment containing 5.0% CO2 for at least 24 hours before initiating 
ethanol treatment. Due to ethanol’s volatility, a method utilizing sealed containers was 
used to maintain ethanol levels in the cultured medium (64). With this method, ethanol 
concentration in the medium can be accurately maintained.  
Immunoblots analysis 
 
The immunoblotting procedure for detecting phosphorylation and expression of 
signal proteins was performed as previously described (65). For cerebellar tissues, the 
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cerebella were homogenized in RIPA buffer [1.0% NP40, 0.5% sodium deoxycholate and 
0.1% SDS in 0.01M Phosphate-buffered saline (PBS)] and centrifuged at 10,000×g. The 
supernatant was collected. For the cultured cells, cells were washed with PBS and lysed 
with RIPA buffer for 10 minutes, solubilized cells were centrifuged, the supernatant was 
collected. Protein concentration was determined using Bio-Rad Kit. After that aliquots of 
equal amounts of the protein were loaded into the lanes of a sodium dodecylsulfate (SDS) 
10.0% polyacrylamide gel.  The proteins were separated by electrophoresis, and the 
separated proteins were transferred to nitrocellulose membranes.  The membranes were 
then blocked with either 5.0% nonfat dry milk or 5.0% BSA (for detection of 
phosphorylation) in 10 mM phosphate-buffered saline (pH 7.4) and 0.05% Tween-20 
(TPBS) at room temperature for one hour to block non-specific immunoreactivity.  
Subsequently, the membranes were incubated with primary antibodies directed against 
signaling proteins for 1-2 hours at room temperature or overnight at 4ºC.  After three 
quick washes in TPBS, the membranes were incubated for 1 hour with a secondary 
antibody conjugated to horseradish peroxidase (Amersham, Arlington Hts. IL) diluted at 
1:2000 in TPBS.  The membranes were washed again with TPBS and the immune 
complexes were detected by the enhanced chemiluminescence method (Amersham).  In 
some cases, the blots were stripped and re-probed with an anti-actin antibody. All of the 
antibodies except anti-p-eIF2α and anti-p-PKR (Thr451) were obtained from Santa Cruz 
Biotechnology (Santa Cruz, CA). The anti-p-eIF2α was purchased from Biosource 
International (Camarillo, CA), and the anti-p-PKR (Thr451) was obtained from Cell 





Immunoprecipitation analysis of protein-protein interaction was performed with a 
previously described procedure (66). Briefly, an aliquot of cell lysate containing 200 µg 
of protein was incubated with the IP antibody (1:50) overnight at 4°C. Twenty microliters 
of protein A/G conjugated to agarose (Santa Cruz Biotech) were added to the lysate, and 
the mixture was incubated 3 h at 4°C. Immunoprecipitates were collected by 
centrifugation at 10,000×g for 10 min. The pellet was washed three times with 0.5 ml 
RIPA buffer [150 mM NaCL, 50 mM Tris (PH 8.0), 1.0% Nonidet P-40, 0.10% SDS, 
0.50% deoxycholic acid sodium, 0.10% mg/ml phenylmethylsulfony fluotide, 1.0 mM 
sodium orthovanadate, and 3.0% Aprotinin (Sigma)]. Then pellets were resuspended in 
20 µl 3× SDS sample buffer and analyzed using the procedures described in the 
immunoblt analysis. 
Protein synthesis assay 
Protein synthesis was measured by incorporation of 14C labeled amino acids 
(Amersham CFB104).  Briefly, cells were seeded in 24-well cell culture trays at the 
density of 5x105 cells/well. After ethanol treatment for the indicated time, 2.5 µCi 14C 
amino acid mix was added to the wells, incubated at 37°C for 15 minutes and then the 
medium was removed; the cells were lysed with 1 vol. cold RIPA buffer. Reactions were 
stopped by the addition of 1 vol. cold 20% TCA. The acid insoluble fraction was 
collected on Whatman glass fiber filters (47 mM GF/A) and radioactivity was measured 
by liquid scintillation counting.  
Statistical Analysis: 
Differences among treatment groups were tested using analysis of variance 
(ANOVA).  Differences in which p was less than 0.05 were considered statistically 
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significant.  In cases where significant differences were detected, specific post-hoc 





Ethanol induces phosphorylation of PKR and eIF2α in SH-SY5Y, SK-N-MC and 
primary cultured rat cerebellar granule cells   
Protein synthesis is crucial for maintaining the normal function of the cell. 
Reduced organ protein content will decrease the abundance of some critical cellular 
components, such as enzymes, and lead to cellular disfunction or cell death. The cellular 
protein content is the result of the dynamic balance between rates of protein synthesis and 
degradation. Previous studies in some non-neuron cells have already shown that ethanol 
exposure can diminish the rate of protein synthesis by upregulating phosphorylation of 
eIF2α (67-72). However the upstream kinases that lead to eIF2α phosphorylation have 
not been determined. In this study, we first tried to determine if eIF2α was involved in 
ethanol-induced protein synthesis inhibition in neural cells; if it is, then what are the 
upstream signaling proteins that lead to eIF2α activation? We treated SH-SY5Y, SK-N-
MC and primary cultured rat cerebellar granule cells with 0.4% ethanol for different time 
points and found that phosphorylation of eIF2α was upregulated after ethanol treatment. 
Since PKR is the best-known physiological activator of eIF2α, we wondered if PKR was 
involved in ethanol-induced eIF2α phosphorylation. We tested the PKR’s activity and 
found that, like eIf2α, PKR was also activated by ethanol treatment (Fig. 3.1).  
 
The expression of phosphorylation of PKR and eIF2α is developmentally regulated 
and both can be induced by ethanol exposure  
To further test the activity of PKR and eIF2α in response to ethanol treatment in 
vivo, we examined the expression of total and phosphorylated forms of PKR and eIF2α in 
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rat cerebellum. The primary targets of ethanol in the developing central nervous system 
are proliferating cells (73) and the neurogenesis of cerebellar granule cells. These 
activities occur during the “brain growth spurt” (the third trimester of pregnancy in 
human and first two postnatal weeks in the rat), therefore making the brain most 
vulnerable to ethanol exposure during this period of time (74). We adopted the pups from 
postnatal day (PD) 3 to 21. In early developing cerebellum, the expression of 
phosphorylated PKR and eIF2α are gradually increased along its development (Fig. 
3.2A). Ethanol exposure during this period of time alters the activation of PKR and 
eIF2α. On PD9 or PD4-9, ethanol intubation upregulated the phosphorylation of PKR and 
eIF2α in the pups’ cerebellum (Fig. 3.2B, C). This result indicated that both PKR and 
eIF2α were activated by ethanol exposure in developing rat cerebellum.  
PKR is the activator of eIF2α upon ethanol treatment. 
To confirm the role of PKR in the effect of ethanol on eIF2α phosphorylation, two 
well known PKR inhibitors (75-77), 2-AP and PKR inhibitor, were used to pre-treat SH-
SY5Y cells 0.5h before ethanol exposure. Both PKR inhibitors can reduce eIF2α 
phosphorylation at concentrations of 10 mM and 500 nM, respectively (Fig. 3.3A, B). 
This, most likely, indicates that PKR is an upstream activator of eIF2α in response to 
ethanol exposure. Then we further tested the effect of ethanol on eIF2α phosphorylation 
in PKR overexpression (PKR+/+) and PKR knock-out (PKR-/-) mouse embryonic 
fibroblasts. Ethanol stimulated eIF2α phosphorylation in PKR+/+, but not in PKR-/- cells 
(Fig. 3.4). This further suggested the crucial role of PKR in ethanol-induced eIF2α 
activation.   
PACT/Rax is an upstream activator of PKR/eIF2α upon ethanol exposure 
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Ethanol-induced activation of PKR/eIF2α apparently does not involve dsRNA. 
So, we wanted to examine the potential upstream activator of PKR. PACT/Rax is a 
characterized protein activator of PKR and functions as the physiological mediator of 
stress-induced PKR activation in the absence of double-stranded RNA. We sought to 
determine whether Rax is involved in ethanol-induced PKR/eIF2α activation. We both 
transiently and stably transfected SK-N-MC cells with wild type and S18A (alanine 
substitution for serine at position 18) Rax genes. As shown in Fig. 3.5, a positive reaction 
of wild type Rax transfected SK-N-MC cells and a negative reaction of S18A transfected 
SK-N-MC cells were detected by immunoblots after ethanol exposure compared to vector 
control. Since PACT/Rax activates PKR through directly binding to its dsRNA binding 
domain, an immunoprecipitation assay was performed to investigate their association 
after ethanol treatment. The association of Rax and PKR is increased dramatically in the 
widetype transiently and stably transfected cells compared to those vector or mutated Rax 
transfected cells (S18A mutated Rax can still bind to PKR but it is kinase deficient (78) 
(Fig. 3.6). To confirm that Rax/PKR/eIF2α is the signal transducting pathway leading to 
protein synthesis inhibition upon ethanol exposure, a protein synthesis assay was 
performed in Rax stably-transfected SK-N-MC cells. The protein synthesis was 
dramatically inhibited in Rax over-expression cells, moderately inhibited in vector 
transfected cells and slightly inhibited in Rax mutated cells (Fig. 3.7). This result 
indicates that the Rax/PKR/eIF2α signal pathway is the major component that mediates 





Heavy, chronic gestational alcohol consumption in pregnant women is detrimental 
to the fetus’ developing nervous system. This alcohol abuse can cause fundamental 
central nervous system abnormalities known as Fetal Alcohol Syndrome (FAS) in the 
infants. One of the hallmarks of FAS is microencephaly that results mainly from the 
decreased protein content of the cerebellum (79). Previous studies have established that 
ethanol exposure can decrease protein synthesis in some non-neural organs via inhibiting 
protein synthesis initiation by regulating the eukaryotic initiation factors (eIFs) in 
translational level (80-82).  In one study, the phosphorylation of eIF2α, a crucial factor 
that controls protein synthesis initiation, can be increased up to 90% by ethanol treatment 
(83). We demonstrate that ethanol exposure can also lead to protein synthesis inhibition 
in SH-SY5Y, SK-N-MC neuroblastoma cell lines, primary cultured cerebellar granule 
cells and rat cerebellum via increasing eIF2α activation. Furthermore, we provide an 
important insight into the intracellular signaling pathway that regulates ethanol-induced 
phosphorylation of eIF2α and protein synthesis inhibition. In both in vitro and in vivo 
experiments, we showed that ethanol exposure induced activation of PKR and led to 
phosphorylation of its downstream substrate eIF2α. By using the specific PKR inhibitors, 
PKR overexpression and knock-out MEFs, we confirmed that PKR was the direct 
activator of eIF2α phosphorylation. We also demonstrated that PACT/Rax was the 
upstream activator of PKR in response to ethanol-induced PKR / eIF2α activation and 
protein synthesis inhibition by using wildtype and S18A mutated Rax tranfected SK-N-
MC cells. 
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In general, the concentration of ethanol used in vivo is higher than that used in vitro 
to produce similar effects. Consequently, the concentrations of ethanol we adopted were 
0.4% (40 µg ethanol per ml medium) in vitro and 11.33% in vivo (113.3 µg ethanol per 
ml milk formula, roughly equal 0.3% blood ethanol concentration). This is a relatively 
high concentration, but it is physiologically relevant to the blood alcohol concentration 
reported to cause Fetal Alcohol Syndrome (84).  
PKR is the direct upstream activator of eIF2α upon ethanol exposure.  
Eukaryotic initiation factor 2 (eIF2), one of a series of proteins that regulated 
protein synthesis initiation in eukaryotic cells, is composed of α, β and γ subunits. 
Phosphorylation at serine 51 of the α-subunit of eIF2 (eIF2α) blocks the formation of a 
ternary initiation complex, which involved eIF2, GTP and Met-tRNAi, and protein 
synthesis initiation will be inhibited. The effect of ethanol on protein synthesis at the 
molecular level has been investigated previously. Lang et al (85) found that ethanol did 
not alter ATP and total RNA content in hepatic cells, but increased the proportion of 40S 
and 60S ribosomal subunits in the nonpolysome-associated fraction by 30%, decreased 
hepatic eIF2B activity by 36%, and increased eIF2α phosphorylation up to 90%. They 
also found similar results in skeletal, muscle and myocardial cells (86;87). Another study 
(88) demonstrated that protein synthesis inhibition induced by ethanol could be overcome 
by addition of eIF2 in the reticulocyte cell-free system. However none of these studies 
have investigated the upstream signal protein(s) leading to eIF2α phosphorylation and 
protein synthesis inhibition. So far four eIF2α kinases have been reported, each of them 
respond to different stimuli: heme-regulated kinase (HRI) by hemin deprivation (89), 
double-stranded RNA-induced protein kinase (PKR) by dsRNA, and PACT/Rax (90;91), 
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GCN2 kinase from yeast (92), Drosophila and mouse (93;94) by amino acid or serum 
starvation, and PKR-like ER kinase (PERK) by unfolded proteins in response to ER-
stress (95). All these kinases can lead to eIF2α phosphorylation and translation initiation 
inhibition (96-98). Among these kinases, PKR is the best characterized eIF2α kinase, and 
recently it has been established that PKR is a component of signal transduction pathways 
mediating cell growth and response to different stresses (99). If PKR was the activator of 
eIF2α with ethanol treatment, we assumed that PKR should have a synonymous reaction 
with eIF2α. Our results confirmed this. Since PERK is another potential protein kinase 
that may lead to eIF2α phosphorylation, we checked the p-PERK and total PERK in these 
experiments and no synonymous alteration of p-PERK was detected (data not show). 
Combined with the results from experiments of PKR inhibitors pre-treatment and PKR 
gene knock out MEFs, we demonstrated that PKR is the upstream kinase of eIF2α and is 
activated by ethanol exposure. 
Ethanol and cerebellum early development 
Meanwhile, we investigated the activation of PKR and eIF2α in rat pup’s 
cerebellum during postnatal day (PD) 3-21, the western blots showed that 
phosphorylation of both was gradually increased, especially after PD9. A possible 
explanation is, during this time, cerebellar neurons switched gradually from proliferation 
to differentiation. Previous studies have demonstrated that PKR and eIF2α function in 
controlling cell proliferation and differentiation (100). Gradually increased activation of 
PKR and eIF2α may control cells slowing down their proliferation rate, and release more 
mRNAs from polysomes of overall protein synthesis to facilitate the translation of 
specific mRNAs that are essential for cellular differentiation processes (101).  Our in vivo 
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experiments showed that intubating pups with ethanol on PD4 or PD4-9 led to up-
regulation of PKR and eIF2α activation. The lasting activation of PKR and eIF2α may be 
the reason that leads to the decrease protein content in the developing cerebellum after 
chronic ethanol exposure.  
Intracellular signaling pathway for ethanol action     
Two activators of PKR have been reported: dsRNA and PACT/Rax. Since previous 
studies have shown that ethanol exposure did not lead to RNA content alteration (102) 
and PACT/Rax is the known intracellular PKR mediator in response to different stresses 
independent of ds-RNA (103;104), PACT/Rax is likely the activator of PKR/eIF2α in 
response to ethanol treatment. To test this hypothesis, we transfected SK-N-MC cells 
with wild type and S18A mutated Rax genes both transiently and stably. There are 15 
phosphorylatable serines within Rax protein sequence, but only those phosphorylated at 
serine 18 are able to activate PKR. The non-phosphorylatable Rax, Rax(S18A), can still 
bind with PKR but since it has lost its kinase activity, it fails to induce eIF2α 
phosphorylation (105). Our western blots showed that phosphorylation of PKR and eIF2α 
were increased significantly in Rax overexpression cells than in Rax mutant cells. Since 
Rax activates PKR through direct association, immunoprecipitation experiments were 
performed to investigate the interaction between Rax and PKR. Our results demonstrated 
that the association between Rax and PKR increased dramatically in wild-type Rax 
transfected cells compared to control cells (PKR can not be activated in mutant cells, for 
mutant Rax has no kinase activity though its interaction increased). In addition, we 
examined the protein synthesis rates in these Rax transfected cells by 14C amino acids 
incorporation assay and the rate is much slower in Rax wildtype cells than in Rax 
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mutated (S18A) cells. The conclusion from these experiments is that PACT/Rax-PKR-
eIF2α is the signaling pathway leading to protein synthesis inhibition upon ethanol 
exposure in cerebellar granule cells.  
Alcohol exposure has a profound effect on central nervous system  development. 
Our study provides an important insight into a potential mechanism for the effect of 
ethanol on the development of CNS. 
 





     Figure 3.1 A. SH-SY5Y cells treated with ethanol (0.4%) 
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Figure 3. 1  Effect of ethanol on PKR and eIF2α activation 
 PKR and eIF2α are activated by ethanol treatment. The expression of phosphorylated 
PKR and eIF2α, total PKR and eIF2α were determined by immunoblots in: A. SH-SY5Y 
cells which were cultured in serum-free medium for 24 h then exposed to ethanol (0 or 
0.4%). B. 293 cells which were cultured in serum-free medium for 24 h before ethanol (0 
or 0.4%) treatment. C. Ethanol (0 or 0.4%) treated primary cultured cerebellar granule 
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Figure 3. 2  Ethanol upregulates phosphorylation of PKR and eIF2α in rat pup's 
creased in pup’s 
cerebellum 
(A). The expression of phosphorylation of PKR and eIF2α, total PKR and eIF2α were 
determined by immunoblots in PD3-21 rat pup’s cerebellum.  
 (B) and (C). The expression of phosphorylation of PKR and eIF2α in
cerebella which were intubated with ethanol (11.33%) plus milk formula on PD4-9 or 
PD9 compared to intubated with milk formula only (control).  






Figure 3. 3  Effect of PKR inhibitors on ethanol-induced eIF2α phosphorylation 
PKR inhibitors block ethanol-induced eIF2α activation. SH-SY5Y cells were maintained 
in serum-free medium for 24 h then pre-treated with 2-AP (10 mM) (A) or PKR inhibitor 
(500 nM) (B) 0.5 h before ethanol (0 or 0.4%) exposure. The expression of 
phosphorylation of eIF2α and total eIF2α were determined by immunoblots. The 









   
 
 
Figure 3. 4  Ethanol fails to induce eIF2α activation in PKR-deficient MEFs 
The PKR+/+ and PKR-/- mouse embryonic fibroblasts were cultured in serum-free 
medium for 24 h before ethanol (0 or 0.4%) treatment. The expression of phosphorylation 
































Figure 3. 5  Effect of ethanol on eIF2α phophorylation in wildtype and serine 18 mutated 
Wildtype Rax gene transfected SK-N-MC cells are more sensitive to ethanol’s action, but 
not in Rax mutant transfected SK-N-MC cells. (A). SK-N-MC cells transiently 
transfected with wild type or serine 18 mutated Rax genes were cultured in serum-free 
medium for 24h before treated with ethanol (0 or 0.4%) for 2, 4 or 6 hours. The 
expression of phosphorylation of eIF2α and PKR, total eIF2α and PKR were determined 
by immunoblots.  
(B). Wild type or serine 18 mutated Rax gene stably transfected SK-N-MC cells were 
cultured in serum-free medium for 24 h then exposed to ethanol (0 or 0.4%) for 2, 4 or 6 
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Figure 3. 6  Ethanol promotes the association between PKR and Rax 
Wild type or serine 18 mutated Rax genes were stably transfected in SK-N-MC cells and 
exposed to ethanol (0 or 0.4%) after 2, 4 and 6 hs. The association of PKR and Rax or 
PKR and HA (tag) was determined by immunoprecipitation using anti-PKR, anti-Rax or 
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Protein synthesis was measured in wildtype and S18A mutated Rax stable transfected
SK-N-MC cells treated with 0.4% ethanol by the incorporation 14C labeled amino acids. 





                                                         
 
1.  Bonthius, D. J., West, J. R. (1990) Alcohol-induced neuronal loss in developing 
rats: increased brain damage with binge exposure. Alcohol Clin.Exp.Res. 14, 107-
118 
 2.  West, J. R. (1993) Acute and long-term changes in the cerebellum following 
developmental exposure to ethanol. Alcohol Alcohol Suppl 2, 199-202 
 3.  Streissguth, A. P., Landesman-Dwyer, S., Martin, J. C., Smith, D. W. (1980) 
Teratogenic effects of alcohol in humans and laboratory animals. Science 209, 
353-361 
 4.  Diamond, I., Gordon, A. S. (1997) Cellular and molecular neuroscience of 
alcoholism. Physiol Rev. 77, 1-20 
 5.  Marcussen, B. L., Goodlett, C. R., Mahoney, J. C., West, J. R. (1994) Developing 
rat Purkinje cells are more vulnerable to alcohol-induced depletion during 
differentiation than during neurogenesis. Alcohol 11, 147-156 
 6.  Streissguth, A. P., O'Malley, K. (2000) Neuropsychiatric implications and long-
term consequences of fetal alcohol spectrum disorders. 
Semin.Clin.Neuropsychiatry 5, 177-190 
 7.  Diaz, J., Samson, H. H. (1980) Impaired brain growth in neonatal rats exposed to 
ethanol. Science 208, 751-753 
8.  Salman, M. S. (2002) The cerebellum: it's about time! But timing is not 
everything--new insights into the role of the cerebellum in timing motor and 
cognitive tasks. J.Child Neurol. 17, 1-9 
 9.  Marien, P., Engelborghs, S., Fabbro, F., De Deyn, P. P. (2001) The lateralized 
 cerebellum: a review and a new hypothesis. Brain Lang 79, 580-600 
Kalant, H., Koob, G. F., Li, T. K., Tabakoff, B. (1998) Effects of moderate 
Exp.Res. 22, 
998-1040 
 12.  Marcus, J. C. (1987) Neurological findings in the fetal alcohol syndrome. 
Neuropediatrics 18, 158-160 
 13.  Eckardt, M. J., File, S. E., Gessa, G. L., Grant, K. A., Guerri, C., Hoffman, P. L., 




 10.  Jones, K. L., Smith, D. W. (1973) Recognition of the fetal alcohol syndrome in 
early infancy. Lancet 2, 999-1001 
 11.  Eckardt, M. J., File, S. E., Gessa, G. L., Grant, K. A., Guerri, C., Hoffman, P. L., 
alcohol consumption on the central nervous system. Alcohol Clin.
  107
alcohol consumption on the central nervous system. Alcohol Clin.Exp.Res. 22, 
998-1040 
1  
ol Clin.Exp.Res. 22, 304-312 
1
ogical 
study. Brain Res. 119, 249-268 
 16.  
a, L. (1986) Prenatal ethanol exposure and cerebellar development in 
rats. Exp.Neurol. 93, 601-609 
 17.  y exposure to ethanol on the protein and DNA 
contents of specific brain regions in the rat. Brain Res. 734, 286-294 
 18.  sis in 
lin.Exp.Res. 28, 
517-525 
 19.   Impaired myocardial 
l intoxication is associated with changes 
in eIF4F. Am.J.Physiol Endocrinol.Metab 279, E1029-E1038 
 20.  ., Jefferson, L. S., Vary, T. C., Kimball, S. R. 
(1999) Chronic alcohol feeding impairs hepatic translation initiation by 
 21.  on, L. S., Kimball, S. R., Vary, T. C. 
(1999) Inhibition of muscle protein synthesis by alcohol is associated with 
 22.  Wu, J. M. (1981) Control of protein synthesis in rabbit reticulocytes. Inhibition of 
 23.  Lang, C. H., Wu, D., Frost, R. A., Jefferson, L. S., Kimball, S. R., Vary, T. C. 
 24.  ., Wu, D., Frost, R. A., Jefferson, L. S., Vary, T. C., Kimball, S. R. 
(1999) Chronic alcohol feeding impairs hepatic translation initiation by 
 25.  Kaufman, R. J. (1999) Double-stranded RNA-activated protein kinase mediates 
 
 4.  Guerri, C. (1998) Neuroanatomical and neurophysiological mechanisms involved
in central nervous system dysfunctions induced by prenatal alcohol exposure. 
Alcoh
 5.  Bauer-Moffett, C., Altman, J. (1977) The effect of ethanol chronically 
administered to preweanling rats on cerebellar development: a morphol
Nathaniel, E. J., Nathaniel, D. R., Mohamed, S., Nathaniel, L., Kowalzik, C., 
Nahnybid
Miller, M. W. (1996) Effect of earl
Vary, T. C., Nairn, A. C., Lang, C. H. (2004) Restoration of protein synthe
heart and skeletal muscle after withdrawal of alcohol. Alcohol C
Lang, C. H., Frost, R. A., Kumar, V., Vary, T. C. (2000)
protein synthesis induced by acute alcoho
Lang, C. H., Wu, D., Frost, R. A
modulating eIF2 and eIF4E. Am.J.Physiol 277, E805-E814 
Lang, C. H., Wu, D., Frost, R. A., Jeffers
modulation of eIF2B and eIF4E. Am.J.Physiol 277, E268-E276 
polypeptide synthesis by ethanol. J.Biol.Chem. 256, 4164-4167 
(1999) Inhibition of muscle protein synthesis by alcohol is associated with 
modulation of eIF2B and eIF4E. Am.J.Physiol 277, E268-E276 
Lang, C. H
modulating eIF2 and eIF4E. Am.J.Physiol 277, E805-E814 
virus-induced apoptosis: a new role for an old actor. Proc.Natl.Acad.Sci.U.S.A 96,
11693-11695 
  108
 26.  
nded RNA of a protein kinase that phosphorylates eukaryotic initiation 
factor 2. Proc.Natl.Acad.Sci.U.S.A 75, 1121-1125 
 27.  
vation of the dsRNA-dependent protein 
kinase (PKR). J.Biol.Chem. 271, 1756-1763 
 28.  )-
ation of the dsRNA-activated protein kinase 
PKR. J.Biol.Chem. 272, 1291-1296 
 29.   
ffector: a new face of death? J.Interferon Cytokine 
Res. 19, 543-554 
 30.   PKR 
activity. Methods 15, 189-198 
 31.  
rth, M. J., Polyak, S. J., Gretch, D. R., Katze, M. G. (1998) Control of 
PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular 
 32.  f and cooperation 
between the double-stranded RNA-binding motifs of the protein kinase PKR. 
 33.  eterologous 
dimerization domains functionally substitute for the double-stranded RNA 
 34.  on-induced PKR 
protein kinase as an apoptotic effector: a new face of death? J.Interferon Cytokine 
 35.  Proud, C. G. (1995) PKR: a new name and new roles. Trends Biochem.Sci. 20, 
 36.  ed protein kinase 
(PKR) in cell regulation. Biochem.Soc.Trans. 25, 509-513 
 37.  ent 
7-114 
 PKR. J.Biol.Chem. 275, 37993-37998 
Levin, D., London, I. M. (1978) Regulation of protein synthesis: activation by 
double-stra
Wu, S., Kaufman, R. J. (1996) Double-stranded (ds) RNA binding and not 
dimerization correlates with the acti
Wu, S., Kaufman, R. J. (1997) A model for the double-stranded RNA (dsRNA
dependent dimerization and activ
Tan, S. L., Katze, M. G. (1999) The emerging role of the interferon-induced PKR
protein kinase as an apoptotic e
Gunnery, S., Mathews, M. B. (1998) RNA binding and modulation of
Gale, M., Jr., Blakely, C. M., Kwieciszewski, B., Tan, S. L., Dossett, M., Tang, 
N. M., Ko
mechanisms of kinase regulation. Mol.Cell Biol. 18, 5208-5218 
Tian, B., Mathews, M. B. (2001) Functional characterization o
J.Biol.Chem. 276, 9936-9944 
Ung, T. L., Cao, C., Lu, J., Ozato, K., Dever, T. E. (2001) H
binding domains of the kinase PKR. EMBO J. 20, 3728-3737 
Tan, S. L., Katze, M. G. (1999) The emerging role of the interfer
Res. 19, 543-554 
241-246 
Williams, B. R. (1997) Role of the double-stranded RNA-activat
Gil, J., Esteban, M. (2000) Induction of apoptosis by the dsRNA-depend
protein kinase (PKR): mechanism of action. Apoptosis. 5, 10
 38.  Patel, C. V., Handy, I., Goldsmith, T., Patel, R. C. (2000) PACT, a stress-
modulated cellular activator of interferon-induced double-stranded RNA-activated 
protein kinase,
  109
 39.  Williams, B. R. (1999) PKR; a sentinel kinase for cellular stress. Oncogene 18,
6112-6120 
 
 40.  Williams, B. R. (2001) Signal integration via PKR. Sci.STKE. 2001, RE2 
 41.   the 
73, 215-225 
 44.  Ito, T., Yang, M., May, W. S. (1999) RAX, a cellular activator for double-
. 
d 
 46.  sphorylation of 
RAX, the PKR activator, is required for PKR activation and consequent 
 47.   Double-stranded (ds) RNA binding and not 
dimerization correlates with the activation of the dsRNA-dependent protein 
 48.  d RNA (dsRNA)-
dependent dimerization and activation of the dsRNA-activated protein kinase 
 49.  M. G. (1999) The emerging role of the interferon-induced PKR 
protein kinase as an apoptotic effector: a new face of death? J.Interferon Cytokine 
 50.  Gunnery, S., Mathews, M. B. (1998) RNA binding and modulation of PKR 
 51.  Romano, P. R., Zhang, F., Tan, S. L., Garcia-Barrio, M. T., Katze, M. G., Dever, 
nt 
 and the E3 
N-terminal domain. Mol.Cell Biol. 18, 7304-7316 
 52.  
D'Acquisto, F., Ghosh, S. (2001) PACT and PKR: turning on NF-kappa B in
absence of virus. Sci.STKE. 2001, RE1 
 42.  Rowe, T. M., Sen, G. C. (2001) Organizations and promoter analyses of the 
human and the mouse genes for PACT, the protein-activator of the interferon-
induced protein kinase, PKR. Gene 2
 43.  Patel, R. C., Sen, G. C. (1998) PACT, a protein activator of the interferon-induced 
protein kinase, PKR. EMBO J. 17, 4379-4390 
stranded RNA-dependent protein kinase during stress signaling. J.Biol.Chem
274, 15427-15432 
 45.  Patel, R. C., Sen, G. C. (1998) PACT, a protein activator of the interferon-induce
protein kinase, PKR. EMBO J. 17, 4379-4390 
Bennett, R. L., Blalock, W. L., May, W. S. (2004) Serine 18 pho
translation inhibition. J.Biol.Chem. 279, 42687-42693 
Wu, S., Kaufman, R. J. (1996)
kinase (PKR). J.Biol.Chem. 271, 1756-1763 
Wu, S., Kaufman, R. J. (1997) A model for the double-strande
PKR. J.Biol.Chem. 272, 1291-1296 
Tan, S. L., Katze, 
Res. 19, 543-554 
activity. Methods 15, 189-198 
T. E., Hinnebusch, A. G. (1998) Inhibition of double-stranded RNA-depende
protein kinase PKR by vaccinia virus E3: role of complex formation
Williams, B. R. (1999) PKR; a sentinel kinase for cellular stress. Oncogene 18, 
6112-6120 
  110
 53.  Clemens, M. J. (1997) PKR--a protein kinase regulated by double-stranded RNA
Int.J.Bioche
. 
m.Cell Biol. 29, 945-949 
 The 
P58 cellular inhibitor complexes with the interferon-induced, double-stranded 
00-
ted 
eptide repeat family of 
proteins. Mol.Cell Biol. 14, 2331-2342 
 56.   Double-stranded RNA-
independent dimerization of interferon-induced protein kinase PKR and inhibition 
443 
 57.   M. Y., Andersson, K., Tenson, T., Ehrenberg, M. (2003) The 
roles of initiation factor 2 and guanosine triphosphate in initiation of protein 




ation between eIF2 alpha(P) and eIF2B and 
causes inhibition in the guanine nucleotide exchange activity of eIF2B. 
 61.  , W., Virgin, H. W., Leib, D. A., Scheuner, D., Kaufman, R. J., 
Eskelinen, E. L., Levine, B. (2002) Regulation of starvation- and virus-induced 
.S.A 
 63.  Chen, G., Bower, K. A., Ma, C., Fang, S., Thiele, C. J., Luo, J. (2004) Glycogen 
th. FASEB J. 18, 1162-1164 
 54.  Polyak, S. J., Tang, N., Wambach, M., Barber, G. N., Katze, M. G. (1996)
RNA-dependent protein kinase, PKR, to regulate its autophosphorylation and 
activity. J.Biol.Chem. 271, 1702-1707 
 55.  Lee, T. G., Tang, N., Thompson, S., Miller, J., Katze, M. G. (1994) The 58,0
dalton cellular inhibitor of the interferon-induced double-stranded RNA-activa
protein kinase (PKR) is a member of the tetratricop
Tan, S. L., Gale, M. J., Jr., Katze, M. G. (1998)
of dimerization by the cellular P58IPK inhibitor. Mol.Cell Biol. 18, 2431-2
Antoun, A., Pavlov,
synthesis. EMBO J. 22, 5593-5601 
Regulation of internal ribosomal entry site-mediated translation by 
phosphorylation of the translation initiation factor eIF2alpha. J.Biol.Chem
19198-19205 
 59.  Antoun, A., Pavlov, M. Y., Andersson, K., Tenson, T., Ehrenberg, M. (2003
roles of initiation factor 2 and guanosine triphosphate in initiation of protein 
synthesis. EMBO J. 22, 5593-5601 
 60.  Sudhakar, A., Ramachandran, A., Ghosh, S., Hasnain, S. E., Kaufman, R. J., 
Ramaiah, K. V. (2000) Phosphorylation of serine 51 in initiation factor 2 alpha
(eIF2 alpha) promotes complex form
Biochemistry 39, 12929-12938 
Talloczy, Z., Jiang
autophagy by the eIF2alpha kinase signaling pathway. Proc.Natl.Acad.Sci.U
99, 190-195 
 62.  Cox, S., Proud, C. G. (1988) The effect of ethanol on polypeptide chain initiation 
in reticulocyte lysates. Inhibition of recycling of initiation factor eIF-2. 
Biochem.Pharmacol. 37, 2045-2049 
synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced 
neuronal dea
  111
 64.  Luo, J., Miller, M. W. (1997) Differential sensitivity of human neuroblastoma cell 
lines to ethanol: correlations with their proliferative responses to mitogenic 
growth factors and expression of growth factor receptors. Alcohol Clin.Exp.Res. 
 65.  n 
iates 6-hydroxydopamine-induced 
neuronal death. FASEB J. 18, 1162-1164 
 66.  
, S. R. 
nges 
etab 279, E1029-E1038 
thy: 
hem.Cell Biol. 
 70.  Vary, T. C., Lynch, C. J., Lang, C. H. (2001) Effects of chronic alcohol 
 71.  Vary, T. C., Nairn, A. C., Lang, C. H. (2004) Restoration of protein synthesis in 
8, 
 72.  ibition of 
l. J.Biol.Chem. 256, 4164-4167 
 74.  Vitalone, A., Guizzetti, M. (2004) Signal transduction mechanisms 
involved in the antiproliferative effects of ethanol in glial cells. Toxicol.Lett. 149, 
 75.   A. (2003) Small molecule inhibitors of the 
RNA-dependent protein kinase. Biochem.Biophys.Res.Commun. 308, 50-57 
 76.  ., 
[d(CGCGAATTCGCG)]2 containing 
21, 1186-1194 
Chen, G., Bower, K. A., Ma, C., Fang, S., Thiele, C. J., Luo, J. (2004) Glycoge
synthase kinase 3beta (GSK3beta) med
Luo, J., West, J. R., Cook, R. T., Pantazis, N. J. (1999) Ethanol induces cell death 
and cell cycle delay in cultures of pheochromocytoma PC12 cells. Alcohol 
Clin.Exp.Res. 23, 644-656 
 67.  Lang, C. H., Wu, D., Frost, R. A., Jefferson, L. S., Vary, T. C., Kimball
(1999) Chronic alcohol feeding impairs hepatic translation initiation by 
modulating eIF2 and eIF4E. Am.J.Physiol 277, E805-E814 
 68.  Lang, C. H., Frost, R. A., Kumar, V., Vary, T. C. (2000) Impaired myocardial 
protein synthesis induced by acute alcohol intoxication is associated with cha
in eIF4F. Am.J.Physiol Endocrinol.M
 69.  Lang, C. H., Kimball, S. R., Frost, R. A., Vary, T. C. (2001) Alcohol myopa
impairment of protein synthesis and translation initiation. Int.J.Bioc
33, 457-473 
consumption on regulation of myocardial protein synthesis. Am.J.Physiol Heart 
Circ.Physiol 281, H1242-H1251 
heart and skeletal muscle after withdrawal of alcohol. Alcohol Clin.Exp.Res. 2
517-525 
Wu, J. M. (1981) Control of protein synthesis in rabbit reticulocytes. Inh
polypeptide synthesis by ethano
 73.  Luo, J., Miller, M. W. (1998) Growth factor-mediated neural proliferation: target 
of ethanol toxicity. Brain Res.Brain Res.Rev. 27, 157-167 
Costa, L. G., 
67-73 
Jammi, N. V., Whitby, L. R., Beal, P.
Fagan, P. A., Spielmann, H. P., Sigurdsson, S., Rink, S. M., Hopkins, P. B
Wemmer, D. E. (1996) An NMR study of 
  112
an interstrand cross-link derived from a distamycin-pyrrole conjugate. Nucleic 
Acids Res. 24, 1566-1573 
Holz, B., Klima 77.  sauskas, S., Serva, S., Weinhold, E. (1998) 2-Aminopurine as a 
fluorescent probe for DNA base flipping by methyltransferases. Nucleic Acids 
 78.  . (2004) Serine 18 phosphorylation of 
RAX, the PKR activator, is required for PKR activation and consequent 
 79.   of early exposure to ethanol on the protein and DNA 
contents of specific brain regions in the rat. Brain Res. 734, 286-294 
 80.   S. R. 
itiation by 
modulating eIF2 and eIF4E. Am.J.Physiol 277, E805-E814 
 81.  
iated with changes 
in eIF4F. Am.J.Physiol Endocrinol.Metab 279, E1029-E1038 
 82.  
ynthesis by ethanol. J.Biol.Chem. 256, 4164-4167 
S. R. 
.Physiol 277, E805-E814 
 85.  Lang, C. H., Wu, D., Frost, R. A., Jefferson, L. S., Vary, T. C., Kimball, S. R. 
ssociated with changes 
in eIF4F. Am.J.Physiol Endocrinol.Metab 279, E1029-E1038 
 87.  
l, S. R. (2003) Alcohol impairs leucine-mediated phosphorylation of 4E-
BP1, S6K1, eIF4G, and mTOR in skeletal muscle. Am.J.Physiol 
 88.  Wu, J. M. (1981) Control of protein synthesis in rabbit reticulocytes. Inhibition of 
Res. 26, 1076-1083 
Bennett, R. L., Blalock, W. L., May, W. S
translation inhibition. J.Biol.Chem. 279, 42687-42693 
Miller, M. W. (1996) Effect
Lang, C. H., Wu, D., Frost, R. A., Jefferson, L. S., Vary, T. C., Kimball,
(1999) Chronic alcohol feeding impairs hepatic translation in
Lang, C. H., Frost, R. A., Kumar, V., Vary, T. C. (2000) Impaired myocardial 
protein synthesis induced by acute alcohol intoxication is assoc
Wu, J. M. (1981) Control of protein synthesis in rabbit reticulocytes. Inhibition of 
polypeptide s
 83.  Lang, C. H., Wu, D., Frost, R. A., Jefferson, L. S., Vary, T. C., Kimball, 
(1999) Chronic alcohol feeding impairs hepatic translation initiation by 
modulating eIF2 and eIF4E. Am.J
 84.  Church, M. W., Gerkin, K. P. (1988) Hearing disorders in children with fetal 
alcohol syndrome: findings from case reports. Pediatrics 82, 147-154 
(1999) Chronic alcohol feeding impairs hepatic translation initiation by 
modulating eIF2 and eIF4E. Am.J.Physiol 277, E805-E814 
 86.  Lang, C. H., Frost, R. A., Kumar, V., Vary, T. C. (2000) Impaired myocardial 
protein synthesis induced by acute alcohol intoxication is a
Lang, C. H., Frost, R. A., Deshpande, N., Kumar, V., Vary, T. C., Jefferson, L. S., 
Kimbal
Endocrinol.Metab 285, E1205-E1215 
polypeptide synthesis by ethanol. J.Biol.Chem. 256, 4164-4167 
  113
 89.  
e. Trends Biochem.Sci. 20, 105-108 
. 
 91.  Ito, T., Yang, M., May, W. S. (1999) RAX, a cellular activator for double-
 92.  Wek, R. C. (1994) eIF-2 kinases: regulators of general and gene-specific 







reticular signaling. Mol.Cell Biochem. 127-128, 255-265 
 98.  vity of 
ell.Biol. 27, 40-56 
R 
1
 101.  H. (1999) Translational control of specific 
genes during differentiation of HL-60 cells. J.Biol.Chem. 274, 14295-14305 
Chen, J. J., London, I. M. (1995) Regulation of protein synthesis by heme-
regulated eIF-2 alpha kinas
 90.  Clemens, M. J. (1997) PKR--a protein kinase regulated by double-stranded RNA
Int.J.Biochem.Cell Biol. 29, 945-949 
stranded RNA-dependent protein kinase during stress signaling. J.Biol.Chem. 
274, 15427-15432 
translation initiation. Trends Biochem.Sci. 19, 491-496 
characterization of a cDNA encoding a protein synthesis initiation factor-2alph
(eIF-2alpha) kinase from Drosophila melanogaster. Homology To yeast 
protein kinase. J.Biol.Chem. 272, 12544-12550 
 94.  Berlanga, J. J., Santoyo, J., de, H. C. (1999) Characterization of a mammalian 
homolog of the GCN2 eukaryotic initiation factor 2alpha kinase. Eur.J.Biochem. 
265, 754-762 
 95.  Harding, H. P., Zhang, Y., Ron, D. (1999) Protein translation and folding are 
coupled by an endoplasmic-reticulum-resident kinase. Nature 39
 96.  Pestova, T. V., Kolupaeva, V. G., Lomakin, I. B., Pilipenko, E. V., Shatsky, I. N
Agol, V. I., Hellen, C. U. (2001) Molecular mechanisms of translation in
in eukaryotes. Proc.Natl.Acad.Sci.U.S.A 98, 7029-7036 l 
 97.  Prostko, C. R., Brostrom, M. A., Brostrom, C. O. (1993) Reversible 
phosphorylation of eukaryotic initiation factor 2 alpha in response to en
Scheper, G. C., van, W. R., Thomas, A. M. (2001) Regulation of the acti
eukaryotic initiation factors in stressed cells. Prog.Mol.Subc
 99.  Tan, S. L., Katze, M. G. (1999) The emerging role of the interferon-induced PK
protein kinase as an apoptotic effector: a new face of death? J.Interferon Cytokine 
Res. 19, 543-554 
 00.  Proud, C. G. (1995) PKR: a new name and new roles. Trends Biochem.Sci. 20, 
241-246 
Krichevsky, A. M., Metzer, E., Rosen, 
  114
 02.  Lang, C. H., Wu, D., Frost, R. A., Jefferson, L. S., Vary, T. C., Kimball, S. 
(1999) Chronic alcohol feeding impairs hepatic translation initia
1 R. 
tion by 
modulating eIF2 and eIF4E. Am.J.Physiol 277, E805-E814 
 103.   a protein activator of the interferon-induced 
protein kinase, PKR. EMBO J. 17, 4379-4390 
 104.   
nthesis by a novel mechanism involving the cellular PKR 
activator RAX. J.Biol.Chem. 276, 11754-11758 
 105.  e 18 phosphorylation of 




Patel, R. C., Sen, G. C. (1998) PACT,
Ruvolo, P. P., Gao, F., Blalock, W. L., Deng, X., May, W. S. (2001) Ceramide
regulates protein sy
Bennett, R. L., Blalock, W. L., May, W. S. (2004) Serin
translation inhibition. J.Biol.Chem. 279, 42687-42693 
  115
Appendix: Detailed Method 
als and ethanol exposure in vivo 
 
1. Anim




were a cerebella 
ere harvested by cutting through the cerebellar peduncles, frozen on dry ice, and stored 
t -80°C for further processing. 
 
2. Immunoblots analysis  
 
Tissues or cells were washed with PBS and lysed with RIPA buffer for 10 
minutes.  Adherent cell fragments were scraped from the dish and the entire lysate was 
transferred to microfuge tubes.  Solubilized cells were centrifuged, the proteinaceous 
supernatant was collected, and protein concentration was determined by Lowry assay (1).  
Aliquots of the supernatant were loaded onto the lanes of a sodium dodecylsulfate (SDS) 
7.5~15.0% polyacrylamide gel.  Each aliquot contained 15~60 µg of protein.  The 
proteins were separated by electrophoresis, and the separated proteins were transferred to 
nitrocellulose membrane.  The membranes were washed with 5.0% nonfat dry milk or 
Albumin from bovine serum (BSA) in 0.010 M phosphate buffered saline (pH 7.4) and 
0.10% Tween-20 (TPBS) at room temperature for one hour to block non-specific 
immunoreactivity.  Subsequently, the membranes were incubated with primary antibodies 
for 1½ hours at room temperature.  After two quick washes in TPBS, the membranes 
Long-Evans rats were obtained from Harlan-Sprague-Dawley (Indianapolis, IN).  
The animals were maintained in a temperature/humidity controlled facility in which t
rk cycle was 12 h/12 h and fed with protein-enriched diets that were nutrition
balanced and met the requirements of pregnant rats (Bio-Serv, Frenchtown NJ).  Pup




were incubated with a seco 0,000 in TPBS for 1 hour.  
with the enhanced chemiluminescence method 
(Amers
e and ethanol exposure in vitro    
 
Isolation and cultures of cerebellar granule neurons were created using a 
reviously described method (2-5). Seven-day-old Sprague Dawley rat pups were 
decapitated and cerebella carefully removed.  The brain tissue was minced with a sterile 
razor blade and suspended in 10 ml of trypsine solution (0.025%) at 37°C.  After 
incubation for 15 min, an equal volume of a solution containing DNAse (130 Knuitz 
units/ml) and trypsine inhibitor (0.75 mg/ml) was added and the tissue was sedimented by 
a brief (5 seconds) centrifugation.  The tissue was dissociated by trituration, and the cell 
suspension was centrifuged through a 4.0% bovine serum albumin solution, which is a 
critical step for increasing neuronal viability.  The cell pellet was resuspended in Eagle’s 
minimal essential medium containing the following supplements: 10.0% fetal bovine 
serum (FBS), 25 mM KCL, 1 mM glutamine, 33 mM glucose, and penicillin (100 
units/ml)/streptomycin (100 µg/ml).  Cell numbers were determined with a 
hemocytometer.  Cells were plated at certain densities into poly-D-lysine (PDL)-coated 
wells.  Cells were incubated at 37°C in a humidified environment containing 5.0% CO2 
ndary antibody diluted at 1:1,000~1
The immune complexes were detected 
ham, Arlington Hts. IL). The blots were stripped and re-probed with an anti- actin 
antibody.  Since ethanol does not affect the expression of actin, the variation in loading 
was normalized against the amount of actin expression in each lane. The relative amount 
of protein imaged on the films was quantified using a Sigma Gel program (Jandel, San 
Rafael, CA). 
 
3. Cerebellar granule cell cultur
p
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for at least 24 hours to permit cell adhesion before initiating further treatment. A method 
utilizing sealed containers (6-8) was used to maintain ethanol levels in the culture 
medium.  With this method, ethanol was added directly to the culture medium in either 
tissue culture trays or dishes.  Then, the trays or dishes were placed in sealed containers 
in which there was an ethanol-containing water bath in the bottom.  The concentration of 
ethanol in the bath was the same as that in the culture medium.  Ethanol from the bath 
evaporates into the air of the sealed container and maintains the ethanol concentration in 
e culture medium.  A small volume of CO2 (60 ml) was injected into the container prior 
anol concentration.  In 
control cultures, the water bath contains no ethanol.  All containers were incubated at 
37°C. Previous studies have shown that this sealed container method accurately 
maintains ethanol concentrations in the culture medium (9). 
 
4. MTT assay 
th
to sealing.  The ethanol bath was changed daily to maintain the eth
   
MTT assay is based on the cleavage of the yellow tetrazolium salt MTT [3-(4,5-
dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide] to purple formazan crystals by 
metabolically active cells (10).  The MTT assay kit was purchased from Roche Molecular 
Biochemicals (Cat. #: 1 465 007, Indianapolis, IN). The cerebellar granule neurons were 
plated into 96-well microtiter plates at certain density with total volume of 100µl. 
Cultures were then treated with either ethanol or kinases inhibitors.  After treatment, ten 
microliters of MTT labeling reagent were added to each well and plates were incubated at 
37°C for 4 h.  Following MTT incubation, the cultures were solubilized and the 
spetrophotometric absorbance of the samples was detected by a microtiter plate reader. 
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The wavelength to measure absorbance of formazan product is 570 nm with a reference 
wavelength of 750 nm.   
 
 
Immunoprecipitates were generated with a previous described method (Luo and 
Miller, 1999).  The cell lysate was collected, and an aliquot containing 200~300 µg of 
protein was incubated with antibody against the protein (1:50 in PBS) for overnight at 
4°C.  Twenty microliters of Protein A/G 
5. Immunoprecipitation      
acid sodium, 0.10 mg/ml 
henylmethylsulfonyl fluoride, 1.0 mM sodium orthovanadate, and 3.0% Aprotinin 
ter the final wash, the supernatant was aspirated.  The pellet was 
resuspended in 20 µl of assay dilution buffer (20 mM MOPs, pH 7.2, 25 mM beta-
glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1mM dithiothretol) and 
then analyzed it using the procedures described in inmmunoblts analysis.   
 
6. Culture of human neuroblastoma cells expressing inducible TrkB    
conjugated to argrose (Santa Cruz Biotech.) 
were added to the lysate, and the mixture was incubated 3 hours at 4°C.  
Immunoprecipitates were collected by centrifugation at 10,000 x g for 10 min.  The pellet 
was washed three times with 0.5 ml RIPA buffer [150 mM NaCl, 50 mM Tris (pH 8.0),  




Human neuroblastoma SH-SY5Y cells expressing inducible TrkB (TB3 and TB8 
cells) were generated under the control of a tetracycline (Tet)-repressible promoter 
element (11).    Cells were cultured in RPMI 1640 containing 10.0% FBS, 2.0 mM 
glutamine and penicillin (100.0 units/ml)/streptomycin (100.0 µg/ml). TB8 cells were 
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maintained in a RPMI 1640 medium contained Tet (1.0 µg/ml; Tet-on condition).  For 
induction of TrkB expression, cells were switched to a Tet-free medium (Tet-off 
ondition) for further treatment. 
7. Apoptosis assay  
 
 
. Northern blot analysis 
  





Accumulation of DNA fragments in the cytoplasm of apoptotic cells was 
determined by ELISA (Roche Molecular Biochemicals).  We have demonstrated that this 
measurement was sensitive to quantify neuronal apoptosis and was consistent with other 
morphometric indices of apoptosis (12-14).  Briefly, the cells were maintained in 96-well 
plates.  After treatment, the cultures were washed twice with 0.01 M PBS, and the 
cultured cells were lysed.  Twenty microliters of cell lysate from each well were mixed
with 80 µl of antibody solution in the coated wells.  The loaded wells were incubated at 
room temperature for 2 h.  Substrate was added to each well after it was washed three 
times in incubation buffer.  After incubation at room temperature for 10-20 min, the 
optical density was measured using a microtiter plate reader with a light filter of 405 nm. 
The readings were used to measure the degree of apoptosis. 
 
8
 conditions.  RNA isolation and hybridization were performed as described 
previously (15).   Thirty µg of total RNA for TrkB was eletrophoresed in 1.2% agarose-
6% formaldehyde gels.  Gels were stained with 2 mg/ml ethidium bromide.  
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Hybridization was performed with 32P-labeled insert DNA isolated from a plasmid 
containing TrkB (16). 
 
9. Protein synthesis assay 
Protein synthesis was measured by incorporation of 14C labled amino acids 
(Amersham CFB104). Cells were seeded in 24-well cell culture trays at the density of 
5x105 cells/well. After ethanol treatment for the indicated time, 2.5µCi 14C amino acid 
mix was added to the wells, incubated at 37°C for 15 minutes and then medium was 
removed, cells were lysed with 1 vol. cold RIPA buffer. Reactions were stopped by the 
addition of 1 vol. Cold 20% TCA. The acid insoluble fraction was collected on Whatman 
glass fiber filters (47mM GF/A) and radioactivity was measured by liquid scintillation 
counting. 
10. Statistics analysis 
were considered statistically 
gnificant.  In cases where significant differences were detected, specific post-hoc 






Differences among treatment groups were tested using analysis of variance 
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